| Poster |
Título del Poster |
Nombre del Solicitante |
Estado |
|
2-P
|
COMPARISON OF HEMATOPOIETIC STEM CELL (HSC) ENGRAFTMENT ON SYNGENEIC AND ALLOGENEIC STROMAL TERRITORIES IN THE ABSENCE OF IMMUNE REACTION |
Igor Resnick
|
Archivo recibido
|
|
4-P
|
IFNa ACTIVATES DORMANT HSCS IN VIVO |
Marieke Essers
|
Archivo recibido
|
|
11-P
|
DIFFERENTIAL LOCALIZATION OF P-SELECTIN AND VON WILLEBRAND FACTOR DURING MEGAKARYOCYTE MATURATION |
Eva Zetterberg
|
Archivo recibido
|
|
12-P
|
ASSESSMENT OF INDUCED BONE MARROW SUPPRESSION AND HEMATOPOIETIC GROWTH FACTORS ON HEPATIC REGENERATION AFTER PARTIAL HEPATECTOMY IN ALBINO RATS. |
Alaa El Din Saad Abd El Hamid
|
Archivo recibido
|
|
13-P
|
ISOLATION, DIFFERENTIATION AND NEUROPROTECTIVE PROPERTIES OF NEURONAL PROGENITORS FROM HUMAN UMBILICAL CORD BLOOD |
Arnon Nagler
|
Archivo recibido
|
|
16-P
|
A DNASE I HYPERSENSITIVE SITE IN THE DISTAL PROMOTER REGION OF THE BCL-6 LOCUS BINDS ZEB1 AND IS RESPONSIBLE FOR TRANSCRIPTIONAL REPRESSION |
Vasiliki Papadopoulou
|
Archivo recibido
|
|
17-P
|
GENOME-WIDE IDENTIFICATION OF BINDING SITES OF EVI1 IN HUMAN MYELOID CELL LINES |
Miren
|
Archivo recibido
|
|
18-P
|
MICRORNA EXPRESSION PROFILES IN UMBILICAL CORD BLOOD CELL LINEAGES |
Michaela Merkerova
|
Archivo recibido
|
|
23-P
|
CHANGES OF NUCLEOLIN EXPRESSION IN PERIPHERAL BLOOD MONONUCLEAR CELLS IN CHILDREN WITH ACUTE LYMPHOBLASTIC LEUKEMIA |
Eliza Maloney
|
Archivo recibido
|
|
24-P
|
THE EFFECT OF P16 ON GLUCOCORTICOID RESPONSES IN A B-CELL LYMPHOBLAST CELL LINE |
Sun Young Kim
|
Archivo recibido
|
|
25-P
|
PERIPHERAL BLOOD LYMPHOCYTE SUBSETS, TREG CELLS AND FOXP3 EXPRESSION IN -THALASSEMIA MAJOR AND -THALASSEMIA TRAIT PATIENTS |
Ela Erdem
|
Archivo recibido
|
|
27-P
|
DIFFERENT RESPONSES TO ADRIAMYCIN AND RADIATION ON RAJI CELLS: A COMPARATIVE MITOCHONDRIAL PROTEOMIC STUDY |
Yujie Jiang
|
Archivo recibido
|
|
28-P
|
COMPARATIVE PROTEOMIC PROFILING OF SUBTYPE M1 AND M2 OF ACUTE MYELOID LEUKEMIA BY TWO-DIMENSIONAL ELECTROPHORESIS (2DE) AND MASS SPECTROMETRY |
Magdalena Luczak
|
Archivo recibido
|
|
31-P
|
THE UNUSUAL MLL REARRANGEMENT IN ACUTE MYELOID LEUKEMIA |
Sarova
|
Archivo recibido
|
|
32-P
|
COMPLEX CHROMOSOMAL ABERRATIONS IN BONE MARROW CELLS OF 86 PATIENTS WITH MYELODYSPLASTIC SYNDROMES (MDS) |
Zuzana Zemanova
|
Archivo recibido
|
|
34-P
|
HIGH RESOLUTION MELTING ANALYSIS FOR THE RAPID DETECTION OF C-KIT MUTATIONS IN CORE BINDING FACTOR-ACUTE MYELOID LEUKEMIA |
Oscar Fuster
|
Archivo recibido
|
|
35-P
|
ANALYSIS OF ACTIVATION INDUCED CYTIDINE DEAMINASE (AID) MRNA AS PREDICTOR OF DISEASE PROGRESSION AND RESPONSE TO THERAPY INB-CELL CHRONIC LYMPHOCYTIC LEUKEMIA |
Hanaa ElAggan
|
Archivo recibido
|
|
37-P
|
DETECTION OF NUMERICAL CHROMOSOME ABERRATIONS IN RARE ACUTE MYELOID LEUKEMIA (AML) CELLS |
Kieran Oloughlin
|
Archivo recibido
|
|
39-P
|
MYELODYSPLASTIC SYNDROMES: USEFULNESS OF GENE EXPRESSION PROFILING FOR PROGNOSIS AND CELL MORPHOLOGY CLASSIFICATION |
Marta Cabezón
|
Archivo recibido
|
|
43-P
|
FRAGMENT LENGTH ANALYSIS SCREENING FOR CEBPA MUTATIONS DETECTION IN ACUTE MYELOID LEUKEMIA |
Oscar Fuster
|
Archivo recibido
|
|
44-P
|
MUTATIONS IN THE IRF ASSOCIATION DOMAIN OF THE TRANSCRIPTION FACTOR GENE ICSBP MAY BE ASSOCIATED WITH LEUKEMOGENESIS IN SHWACHMAN-DIAMOND SYNDROME |
Noreen Otto
|
Archivo recibido
|
|
45-P
|
A NEW RELIABLE FISH METHOD FOR IDENTIFYING MULTIPLE SPECIFIC CYTOGENETIC ABNORMALITIES IN ACUTE MYELOID LEUKEMIA |
Ana Valencia
|
Archivo recibido
|
|
46-P
|
ACUTE MYELOID LEUKEMIA WITH BIALLELIC CEBPA GENE MUTATIONS AND NORMAL KARYOTYPE REPRESENTS A DISTINCT GENETIC ENTITY ASSOCIATED WITH A FAVORABLE CLINICAL OUTCOME |
Annika Dufour
|
Archivo recibido
|
|
53-P
|
PROGNOSTIC SIGNIFICANCE OF TELOMERE LENGTH, MOLECULAR CYTOGENETIC FINDINGS AND IMMUNOPHENOTYPIC FEATURES IN PATIENTS WITH B-CHRONIC LYMPHOCYTIC LEUKEMIA |
Brezinova
|
Archivo recibido
|
|
56-P
|
FREQUENT MONITORING OF WILMS TUMOR GENE (WT1) EXPRESSION LEVELS IN PERIPHERAL BLOOD FOR EARLY DIAGNOSIS OF ACUTE LEUKEMIA RELAPSE AFTER ALLOGENEIC STEM CELL TRANSPLANTATION |
Ruri Kato
|
Archivo recibido
|
|
57-P
|
DNA METHYLATION PROFILES OF DIFFERENT LYMPHOID MALIGNANCIES |
Carmen Stanganelli
|
Archivo recibido
|
|
61-P
|
FLOW CYTOMETRIC DETECTION OF NG2 ANTIGEN FOR EARLY IDENTIFICATION OF CHILDHOOD ACUTE LEUKEMIAS WITH MLL GENE REARRANGEMENTS |
Lukasz Sedek
|
Archivo recibido
|
|
63-P
|
A NOVEL CHROMOSOMAL TRANSLOCATION T(11;14)(Q24.1;Q32) INVOLVING IGH IN CHILDHOOD B-CELL PRECURSOR ACUTE LYMPHOBLASTIC LEUKAEMIA (BCP-ALL) |
Dufour Carlo
|
Archivo recibido
|
|
65-P
|
TARGETING LEWIS Y-EXPRESSING MULTIPLE MYELOMA AND ACUTE MYELOID LEUKEMIA WITH GENE-MODIFIED T CELLS DEMONSTRATING MEMORY PHENOTYPE |
Stefan Peinert
|
Archivo recibido
|
|
66-P
|
PEPTIDE VACCINATION ELICITS LEUKEMIA-ASSOCIATED ANTIGEN-SPECIFIC CYTOTOXIC CD8 T-CELL RESPONSES WITH POTENTIAL CLINICAL RELEVANCE IN PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA |
Krzysztof Giannopoulos
|
Archivo recibido
|
|
69-P
|
CLINICAL RESPONSES IN ALLOGRAFTED ACUTE LEUKEMIA PATIENTS WITH RESISTANT DISEASE USING A COMBINED CHEMO-IMMUNOTHERAPEUTIC TREATMENT STRATEGY |
Giovanni Fernando Torelli
|
Archivo recibido
|
|
73-P
|
IN VITRO ACTIVATION OF MYELOMA-SPECIFIC CYTOTOXIC T CELLS BY MUC1 PULSED DENDRITIC CELLS |
Fedor Kryukov
|
Archivo recibido
|
|
74-P
|
CYTOKINE INDUCED KILLER CELLS : IN VITRO DIFFERENTIATED T CELLS WITH ANTI-TUMORAL ACTIVITY |
Martino Introna
|
Archivo recibido
|
|
75-P
|
A NOVEL DASATINIB-SENSITIVE RCSD1-ABL1 FUSION TRANSCRIPT IN CHEMOTHERAPY-REFRACTORY ADULT PRE-B LYMPHOBLASTIC LEUKEMIA WITH T(1;9)(Q24;Q34) |
Satu Mustjoki
|
Archivo recibido
|
|
76-P
|
LONG-TERM FOLLOW-UP OF HIV-INFECTED ADULT PATIENTS WITH BURKITTS LYMPHOMA OR LEUKEMIA TREATED WITH INTENSIVE SPECIFIC CHEMOTHERAPY AND RITUXIMAB |
Albert Oriol
|
Archivo recibido
|
|
77-P
|
THE LONG-TERM OUTCOME OF ELDERLY PATIENTS WITH PHILADELPHIA-POSITIVE ACUTE LYMPHOBLASTIC LEUKEMIA (PHALL) IN THE IMATINIB ERA |
Delannoy
|
Archivo recibido
|
|
78-P
|
THE HUMORAL IMMUNE RESPONSE DURING THE L-ASPARAGINASE THERAPY THREE CLASSES OF ANTIBODIES |
Beata Zalewska-Szewczyk
|
Archivo recibido
|
|
80-P
|
QUALITATIVE AND QUANTITATIVE CONCORDANCE IN MRD DATA, ASSESSED BY FLOW CYTOMETRY AND RT-PCR OF FUSION GENE TRANSCRIPTS IN INFANTS WITH MLL-REARRANGED ALL |
Alexander Popov
|
Archivo recibido
|
|
81-P
|
OUTCOME FOR ADOLESCENT AND YOUNG ADULTS UP TO AGE 35 YEARS (AYA) WITH ACUTE LYMPHOBLASTIC LEUKEMIA (ALL) TREATED ON THE PEDIATRIC PROTOCOLS OF MOSCOW-BERLIN 91 AND 2002 |
Sergey Semochkin
|
Archivo recibido
|
|
82-P
|
HUMORAL IMMUNITY TO DIPHTHERIA, TETANUS, MEASLES, AND HAEMOPHILUS INFLUENZAE TYPE B IN CHILDREN WITH ACUTE LYMPHOBLASTIC LEUKEMIA AND RE-VACCINATION RESPONSES |
Emine Zengin
|
Archivo recibido
|
|
83-P
|
PROGNOSTIC SIGNIFICANCE OF ULTRASOUND-DETECTED BOWEL WALL THICKENING IN NEUTROPENIC ENTEROCOLITIS |
mervat Atfy Mohamed
|
Archivo recibido
|
|
84-P
|
EARLY AND LATE RESPONSE ASSESSMENT WITH FDG-PET AFTER BEACOPP-BASED CHEMOTHERAPY IN ADVANCED-STAGE HODGKIN LYMPHOMA PATIENTS HAS A HIGH NEGATIVE PREDICTIVE VALUE |
Jana Markova, Carsten Kobe
|
Archivo recibido
|
|
87-P
|
EARLY FDG-PET SCAN CONFIRMS ITS PROGNOSTIC IMPACT ALSO IN LOCALIZED STAGE, ABVD TREATED HODGKIN LYMPHOMA PATIENTS |
Luigi Rigacci
|
Archivo recibido
|
|
89-P
|
QUALITY OF LIFE AND FERTILITY IN HODGKIN DISEASE (HD) PATIENTS TREATED WITH ESCALATED BEACOPP |
Wojceich Jurczak
|
Archivo recibido
|
|
93-P
|
PLASMA LEVELS OF CIRCULATING CELL-FREE DNA AND OF CYTOKINES AS POTENTIAL BIOMARKERS IN HODGKIN LYMPHOMA |
Stefan Hohaus
|
Archivo recibido
|
|
95-P
|
ANTHRACYCLINE CARDIOTOXITY OCCURS EARLY DURING THERAPY IN CHILDREN WITH HODGKINS DISEASE |
azza tantawy
|
Archivo recibido
|
|
99-P
|
Comparative Study of Two MOPP-Derived Chemotherapeutic Protocols for Management of Pediatric Hodgkins Disease: Single Center 5-year Experience |
Professor Youssef AL-Tonbary
|
Archivo recibido
|
|
101-P
|
RECURRENT MUTATIONS IDENTIFIED ON LMAN1 AND COAGULATION FACTORS VII, X, XIII GENES |
Andrea Cairo
|
Archivo recibido
|
|
104-P
|
THE HEMOSTATIC POTENTIAL OF ACUTE PROMYELOCYTIC LEUKEMIA (APL) CELLS BY THE CALIBRATED AUTOMATED THROMBOGRAM ASSAY (CAT): MODULATION BY ARSENIC TRIOXIDE (ATO) AND ALL-TRANS RETINOIC ACID (ATRA) |
Anna Falanga
|
Archivo recibido
|
|
105-P
|
SINGLE CENTRE EXPERIENCE OF DESMOPRESSIN RESPONSE IN CHILDREN WITH MILD FVIII DEFICIENCY, VON WILLEBRANDS DISEASE AND PLATELET FUNCTION DEFECTS |
Karen Breen
|
Archivo recibido
|
|
112-P
|
INCIDENCE OF LUPUS ANTICOAGULANT IN HEMOPHILIA PATIENTS |
Valeriya Krasivska
|
Archivo recibido
|
|
113-P
|
INDIVIDUALISED ORAL VITAMIN K FOR REVERSAL OF WARFARIN EXCESSIVE ANTICOAGULATION |
Montserrat Briz
|
Archivo recibido
|
|
114-P
|
NOVEL ASSOCIATION BETWEEN ACQUIRED TYPE 2 VON WILLEBRAND DISEASE AND GLYCOGEN STORAGE DISEASE IA (GSD IA): A REPORT OF 3 AFFECTED SIBLINGS |
Youssef Sorour
|
Archivo recibido
|
|
116-P
|
FUNCTIONAL CHARACTERIZATION OF FIBRINOGEN POZNAN: A PREMATURE TRUNCATING MUTATION IN FGG ASSOCIATED WITH HYPOFIBRINOGENEMIA AND MILD BLEEDING TENDENCY |
Krystyna Zawilska
|
Archivo recibido
|
|
118-P
|
PHYSICAL ACTIVITY AS PREVENTION OF OSTEOPOROSIS IN PATIENTS WITH SEVERE HAEMOPHILIA ON LONG TERM PROPHYLAXIS |
Mohammed khawaji
|
Archivo recibido
|
|
121-P
|
ACQUIRED HAEMOPHILIA; A COHORT OF 26 PATIENTS DIAGNOSED AND TREATED IN SOUTH LONDON AND THE SOUTH EAST OF ENGLAND BETWEEN JAN 1996-2009 |
Fateha Chowdhury
|
Archivo recibido
|
|
122-P
|
COAGULATION SCREENING IN AN IRISH TEACHING HOSPITAL |
Johnny McHugh
|
Archivo recibido
|
|
123-P
|
VALIDATION OF THE BRAZILIAN PORTUGUESE VERSION OF THE MEDICAL OUTCOMES STUDY - SOCIAL SUPPORT SURVEY IN HODGKIN LYMPHOMA SURVIVORS |
Andréa Soares
|
Archivo recibido
|
|
125-P
|
HEALTH-RELATED QUALITY OF LIFE AFTER AUTOLOGOUS STEM CELL TRANSPLANTATION: A MULTICENTRE PROSPECTIVE STUDY IN THE CZECH REPUBLIC (FINAL RESULTS) |
Vaclav Kajaba
|
Archivo recibido
|
|
126-P
|
INFLUENCE OF ANEMIA ON QOL, CLINICAL SYMPTOMS AND COGNITIVE FUNCTIONS IN NEWLY DIAGNOSED (NOT TREATED) HEMATOLOGIC PATIENTS |
Duska Petranovic
|
Archivo recibido
|
|
127-P
|
HOME CARE FOR UNFIT ELDERLY PATIENTS WITH MYELODISPLASTIC SYNDROMES: AN ITALIAN SINGLE-CENTER EXPERIENCE |
Pierluigi Alfieri
|
Archivo recibido
|
|
128-P
|
PAIN MANAGEMENT OF BORTEZOMIB-INDUCED NEUROPATHY WITH ORAL CONTROLLED-RELEASE OXYCODONE |
Claudio Cartoni
|
Archivo recibido
|
|
137-P
|
GENETIC VARIATIONS IN HEPARANASE GENE (HPSE) ARE ASSOCIATED WITH INCREASED RISK OF GRAFT VS. HOST DISEASE (GVHD) FOLLOWING ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION (HSCT) |
Olga Ostrovsky
|
Archivo recibido
|
|
138-P
|
IMMUNE RECONSTITUTION AND RISK OF CYTOMEGALOVIRUS INFECTION IN PATIENTS AFTER ALLOGENEIC STEM CELL TRANSPLANTATION: IMPLICATIONS FOR PREEMPTIVE AND PROPHYLACTIC STRATEGIES |
Martin Schmidt-Hieber
|
Archivo recibido
|
|
139-P
|
EXPANSION AND SUPPRESSIVE FUNCTION OF UMBILICAL CORD BLOOD REGULATORY T CELLS |
Giovanni Fernando Torelli
|
Archivo recibido
|
|
140-P
|
THE MODULATORY PROPERTIES OF REGULATORY T CELLS IN THE PERIPHERAL BLOOD OF PATIENTS WHO HAVE UNDERGONE AN ALLOGENEIC STEM CELL TRANSPLANT CORRELATE WITH THE PRESENCE OF GRAFT-VERSUS-HOST DISEASE |
Giovanni Fernando Torelli
|
Archivo recibido
|
|
143-P
|
ALLOANTIGEN-SPECIFIC DE NOVO INDUCED FOXP3 REGULATORY T CELLS FAIL TO PREVENT GVHD DUE TO IN VIVO INSTABILITY |
Christian Koenecke
|
Archivo recibido
|
|
148-P
|
IMPACT OF MINOR HISTOCOMPATIBILITY ANTIGEN MISMATCHES ON GRAFT-VERSUS-HOST DISEASE IN NON-MYELOABLATIVE OR REDUCED INTENSITY ALLOGENEIC STEM CELL TRANSPLANTATION |
Cristiana Carniti
|
Archivo recibido
|
|
149-P
|
CHARACTERIZATION OF T CELL RECEPTOR ?ETA REPERTOIRE IN T CELL POPULATION ASSOCIATED WITH GRAFT-VERSUS-HOST AND GRAFT-VERSUS-LEUKEMIA EFFECT |
Veronika Foltankova
|
Archivo recibido
|
|
151-P
|
GENETIC MISMATCH IN GSTT1 IS ASSOCIATED WITH HEPATIC ACUTE GRAFT VERSUS HOST DISEASE (GVHD) IN ALLOGENEIC STEM CELL TRANSPLANTATION (ALLO-SCT) |
R. Cardesa
|
Archivo recibido
|
|
152-P
|
SECONDARY PROPHYLAXIS OF INVASIVE FUNGAL INFECTIONS IN ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANT RECIPIENTS: A RETROSPECTIVE STUDY OF 73 CASES AT A SINGLE INSTITUTION |
Fang Liu
|
Archivo recibido
|
|
153-P
|
NATURAL KILLER CELL NUMBERS POST STEM CELL TRANSPLANT ARE STRONGLY ASSOCIATED WITH DONOR CHIMERISM AND ARE INCREASED FOLLOWING UMBILICAL CORD STEM CELL TRANSPLANT |
Ursalan Khan
|
Archivo recibido
|
|
154-P
|
ASSOCIATION BETWEEN PLASMA LEVEL CHANGES OF ENDOTHELIAL INJURY MARKERS AND GRAFT VERSUS HOST DISEASE IN PATIENTS TREATED WITH ALLOGENEIC HAEMATOPOIETIC STEM CELL TRANSPLANTATION |
Anna Czyz
|
Archivo recibido
|
|
155-P
|
HUMAN MESENCHYMAL STROMAL CELLS EXPANDED WITH HUMAN PLATELET LYSATE ARE SAFE AND EFFECTIVE FOR THE TREATMENT OF STEROID-REFRACTORY GRAFT VERSUS HOST DISEASE |
Martino Introna
|
Archivo recibido
|
|
156-P
|
HIGH CYTOMEGALOVIRUS (CMV)-SPECIFIC CD8 TEMRA CONTENT IN DONOR GRAFT PREDICTS A LOW RISK OF CMV REACTIVATION FOLLOWING UNMANIPULATED ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION |
Wang Feng-Rong
|
Archivo recibido
|
|
157-P
|
PROPHYLAXIS WITH MYCOPHENOLATE MOFETIL AND CYCLOSPORINE CAN DECREASE THE INCIDENCE OF SEVERE ACUTE GRAFT-VERSUS-HOST DISEASE FOLLOWING REDUCED INTENSITY CONDITIONING ALLOGENEIC STEM CELL TRANSPLANTATION FROM MATCHED UNRELATED DONORS |
Eolia Brissot
|
Archivo recibido
|
|
158-P
|
DONOR LYMPHOCYTE INFUSIONS FOR CHRONIC MYELOID LEUKAEMIA RELAPSING AFTER ALLOGENEIC STEM CELL TRANSPLANT: PROGNOSTIC FACTORS FOR A PURE GVL EFFECT ARE DIFFERENT ACCORDING TO THE STAGE OF RELAPSE |
Cesare Guglielmi
|
Archivo recibido
|
|
159-P
|
EFFICACY OF RITUXIMAB AND DONOR LYMPHOCYTE INFUSIONS AS SALVAGE TREATMENT IN LYMPHOMA PATIENTS RELAPSED AFTER REDUCED INTENSITY ALLOGENEIC STEM CELL TRANSPLANTATION |
Francesco Spina
|
Archivo recibido
|
|
160-P
|
ACUTE LUNG INJURY AFTER ALLOGENEIC HEMTOPOIETIC STEM CELL TRANSPLANTATION (HSCT) IS ASSOCIATED WITH INFERIOR SURVIVAL A RANDOMIZED TRIAL ON THE EFFECTS OF EARLY NON-INVASIVE VENTILATION (NIV) |
Wermke
|
Archivo recibido
|
|
161-P
|
THERAPEUTIC DRUG MONITORING IS AN IMPORTANT FACTOR DURING IV BUSULFAN TREATMENT |
Reta Malr
|
Archivo recibido
|
|
165-P
|
CLINICAL IMPLICATIONS OF PULMONARY FUNCTION TESTS IN ALLOGENEIC STEM CELL RECIPIENTS |
Sang Kyun Sohn
|
Archivo recibido
|
|
166-P
|
HUMAN BONE MARROW AS SOURCE OF STEM CELLS FOR INTRAPANCREATIC TRANSPLANTATION IN IMMUNODEFICIENT MICE: EVIDENCE OF PANCREATIC-CELL LINEAGE COMMITMENT BY GENE EXPRESSION ANALYSIS |
Maria Teresa Arce-Franco
|
Archivo recibido
|
|
167-P
|
RESULT OF DOUBLE UNITS CORD BLOOD TRANSPLANTATION IN CHILDREN AND ASSOCIATION OF CFU-GM WITH THE DETERMINATION OF DOMINANCY |
Hyoung Jin Kang
|
Archivo recibido
|
|
168-P
|
A PHASE I STUDY OF CLOFARABINE PLUS HIGH DOSE MELPHALAN AS A CONDITIONING REGIMEN FOR ALLOGENEIC TRANSPLANTATION |
Mark Kirschbaum
|
Archivo recibido
|
|
169-P
|
PROGNOSTIC VALUE OF POSITRON EMISSION TOMOGRAPHY/COMPUTED TOMOGRAPHY (PET/CT) IN PATIENTS WITH LYMPHOMA TREATED WITH AUTOLOGOUS STEM CELL TRANSPLANTATION FOR RELAPSED/REFRACTORY OR HIGH RISK DISEASE |
Piero Maria Stefani
|
Archivo recibido
|
|
174-P
|
PHARMACOLOGY OF CPX-351: A NANO-SCALE LIPOSOMAL FIXED MOLAR RATIO CYTARABINE-DAUNORUBICIN FOR PATIENTS WITH ADVANCED LEUKEMIA |
Arthur Louie
|
Archivo recibido
|
|
175-P
|
UTILIZING CELL-BASED SCREENING TO IDENTIFY NOVEL USES FOR EXISTING DRUGS: INDUCING SPECIFIC APOPTOSIS OF B-CELL LYMPHOCYTES |
Teresa Bennet
|
Archivo recibido
|
|
178-P
|
D EPITOPE EVALUATION OF THE 25 RHESUS D SPECIFIC IGG1 ANTIBODIES IN ROZROLIMUPAB (SYM001), THE FIRST RECOMBINANT POLYCLONAL ANTIBODY PRODUCT |
Margareta Wikén
|
Archivo recibido
|
|
179-P
|
IBRITUMOMAB TIUXETAN IN LYMPHOMA- A SINGLE CENTRE EXPERIENCE FROM KUWAIT |
Anish Nair
|
Archivo recibido
|
|
183-P
|
IN VITRO ANALYSIS OF NOVEL ANTI-CD20 ANTIBODY GA101 AND RITUXIMAB IN MANTLE CELL LYMPHOMA |
Daniel Heinrich
|
Archivo recibido
|
|
184-P
|
EFFECTS OF THE PI3 KINASE/MTOR INHIBITOR NVP-BEZ235 ON GROWTH AND IGE-DEPENDENT MEDIATOR RELEASE IN HUMAN BASOPHILS AND MAST CELLS |
Katharina Blatt
|
Archivo recibido
|
|
187-P
|
LENALIDOMIDE IN ELDERLY PATIENTS WITH MANTLE CELL LYMPHOMA |
Adrian Tempescul
|
Archivo recibido
|
|
188-P
|
BINDING OF THE RECOMBINANT POLYCLONAL ANTI-D PRODUCT ROZROLIMUPAB (SYM001) AND PLASMA DERIVED ANTI-D TO RHD VARIANTS |
Margareta Wikén
|
Archivo recibido
|
|
189-P
|
CD200, A CELL SURFACE PROTEIN WITH IMMUNOREGULATORY FUNCTION, IS A NEW POTENTIAL TARGET FOR HEMATOLOGIC MALIGNANCIES IMMUNOTHERAPY |
Lorenzo Brunetti
|
Archivo recibido
|
|
190-P
|
SUCCESSFUL TREATMENT WITH BEVACIZUMAB IN POEMS-SYNDROME |
Veronika Buxhofer-Ausch
|
Archivo recibido
|
|
191-P
|
SLUG AND ERK (P42-44): NEW TARGETS IN CHRONIC MYELOID LEUKEMIA THERAPY |
Manuela Mancini
|
Archivo recibido
|
|
195-P
|
THE EFFICACY OF IRON CHELATOR REGIMES IN REDUCING CARDIAC AND HEPATIC IRON IN PATIENTS WITH THALASSAEMIA MAJOR: A CLINICAL OBSERVATIONAL STUDY |
Vasilios Berdoukas
|
Archivo recibido
|
|
196-P
|
INCREASED PLASMA LEVELS OF NGAL AND IL-18 CORRELATE WITH REDUCED GFR PROVIDING EVIDENCE OF TUBULOGLOMERULAR DEFECT IN PATIENTS WITH HBS/BETA-THALASSEMIA |
Ioannis Papassotiriou
|
Archivo recibido
|
|
197-P
|
ANALYSIS OF IRON HOMEOSTASIS AND ERYTHROID ACTIVITY IN A COHORT OF LOW-RISK MYELODYSPLASTIC PATIENTS |
Emanuela Messa
|
Archivo recibido
|
|
198-P
|
MYOCARDIAL LESIONS AND IRON DEPOSITS AFTER TREATMENT WITH ANTHRACYCLINES |
Almudena Cascales
|
Archivo recibido
|
|
203-P
|
OUTCOMES OF PATIENTS WITH SICKLE CELL DISEASE ADMITTED TO THE INTENSIVE THERAPY UNIT A SINGLE INSTITUTION EXPERIENCE |
Kate Gardner
|
Archivo recibido
|
|
204-P
|
TREATMENT WITH DEFERASIROX EFFECTIVELY DECREASES IRON BURDEN IN PATIENTS WITH THALASSEMIA INTERMEDIA |
Christoulas Dimitrios
|
Archivo recibido
|
|
205-P
|
ACUTE SPLENIC SEQUESTRATION IN SICKLE CELL DISEASE (SCD) |
Valentine Brousse
|
Archivo recibido
|
|
208-P
|
ASSESSMENT OF NON-TRANSFERRIN BOUND IRON IN THALASSEMIC SERA USING A NEW FLUORESCENCE BASED ASSAY |
Nivedita K Gohil
|
Archivo recibido
|
|
214-P
|
DO WE HAVE TO RECONSIDER FERRITIN OPTIMAL LEVELS IN MULTITRANSFUSED THALASSAEMIA MAJOR PATIENTS? |
Kallistheni Farmaki
|
Archivo recibido
|
|
215-P
|
TREATMENT WITH DEFERASIROX EFFECTIVELY DECREASES IRON BURDEN IN PATIENTS WITH SICKLE CELL SYNDROMES |
Christoulas Dimitrios
|
Archivo recibido
|
|
217-P
|
RELEVANCE OF ALPHA HEMOGLOBIN STABILIZING PROTEIN POLYMORPHISMS IN SICKLE CELL DISEASE PATIENTS FROM OMAN |
Shoaib Al Zadjali
|
Archivo recibido
|
|
218-P
|
NON-TRANSFERRIN-BOUND IRON: A NOVEL INDICATOR OF IRON OVERLOAD IN PATIENTS WITH SICKLE CELL DISEASE |
Adlette Inati
|
Archivo recibido
|
|
219-P
|
OUTCOME OF PREGNANCY IN SICKLE CELL SYNDROMES. A SINGLE CENTER STUDY |
Eleni Plata
|
Archivo recibido
|
|
221-P
|
IMPLEMENTATION, EFFICACY AND SAFETY OF A BLOOD CONSERVATION PROTOCOL IN PATIENTS UNDERGOING SURGERY FOR HIP FRACTURE REPAIR. AN ANALYSIS OF 399 CONSECUTIVE PROCEDURES |
Dr José Antonio García-Erce
|
Archivo recibido
|
|
222-P
|
OXIDANT-ANTIOXIDANT SYSTEM AND LYMPHOCYTE DNA DAMAGE IN BETA THALASSEMIA CHILDREN |
Poster Presentation
|
Archivo recibido
|
|
223-P
|
DISORDERS OF GLUCOSE METABOLISM ARE A MAJOR ENDOCRINE COMPLICATION IN OMANI THALASSAEMICS |
Shahina Daar
|
Archivo recibido
|
|
224-P
|
OXYDATIVE STRESS AND ERYTHROPOIETIN REDUCTION DURING AND AFTER A FOURTEEN DAYS SCUBA DIVE |
Bianca Maria Ricerca
|
Archivo recibido
|
|
225-P
|
ENDOSOMAL TRANSPORT OF TRANSFERRIN TO MITOCHONDRIA IS ESSENTIAL FOR EFFICIENT UTILIZATION OF IRON FOR HEME SYNTHESIS |
Prem Ponka
|
Archivo recibido
|
|
229-P
|
USE OF FONDAPARINUX IN PATIENTS WITH SUSPECTED HEPARIN-INDUCED THROMBOCYTOPENIA |
Edelmira Marti Saez
|
Archivo recibido
|
|
230-P
|
THE HOSPITALIZATION NEED AND COST OF ADULT PRIMARY IMMUNE THROMBOCYTOPENIA (ITP) TREATMENT: A MONOCENTRIC EVALUATION |
Marco Ruggeri
|
Archivo recibido
|
|
232-P
|
STUDY OF THE IN VITRO EFFECT OF THE NONPEPTIDE THROMBOPOIETIN -RECEPTOR AGONIST SB-497115 (ELTROMBOPAG) ON MEGAKARYOPOIESIS OF PATIENTS WITH LOW/INTERMEDIATE-I RISK MYELODYSPLASTIC SYNDROME |
Helen Papadaki
|
Archivo recibido
|
|
233-P
|
IMPROVEMENT IN FATIGUE AND HEALTH-RELATED QUALITY OF LIFE (HRQOL) WITH LONG-TERM ELTROMBOPAG THERAPY IN CHRONIC IDIOPATHIC THROMBOCYTOPENIC PURPURA (ITP): RESULTS OF PHASE 3, DOUBLE-BLIND STUDY(RAISE) |
GlaxoSmithKline
|
Archivo recibido
|
|
234-P
|
USEFULNESS OF PRETEST CLINICAL SCORES (4TS) AND THEIR CORRELATION WITH THE RAPID ID-HEPARIN / PF4 ANTIBODY TESTING FOR THE DIAGNOSIS OF HEPARIN INDUCED THROMBOCYTOPENIA |
Dr Kiran Mathur
|
Archivo recibido
|
|
235-P
|
PROSPECTIVE STUDY OF ABBREVIATED COURSE RITUXIMAB FOR AUTOIMMUNE HAEMATOLOGICAL DISORDERS REFRACTORY TO STANDARD IMMUNOSUPPRESSIVE THERAPY |
Andrew Grigg
|
Archivo recibido
|
|
236-P
|
CHRONIC IDIOPATHIC THROMBOCYTOPENIC PURPURA THERAPIES: THE PATIENTS PERSPECTIVE ON BOTHERSOME EFFECTS |
GlaxoSmithKline
|
Archivo recibido
|
|
237-P
|
THROMBOPOIETIN RECEPTOR (CMPL) EXPRESSION IN INHERITED AND ACQUIRED PLATELET DISORDERS |
Silvia Vettore
|
Archivo recibido
|
|
238-P
|
EFFICACY AND SAFETY OF INTRAVENOUS ANTI-D TREATMENT OF PATIENTS WITH REFRACTORY AUTOIMMUNE THROMBOCYTOPENIC PURPURA |
Marina Mantzourani
|
Archivo recibido
|
|
239-P
|
IMPROVEMENT IN FATIGUE AND HEALTH-RELATED QUALITY OF LIFE (HRQOL) WITH LONG-TERM ELTROMBOPAG TREATMENT IN ADULTS WITH CHRONIC IDIOPATHIC THROMBOCYTOPENIC PURPURA (ITP): THE EXTEND STUDY |
GlaxoSmithKline
|
Archivo recibido
|
|
240-P
|
MICOPHENOLAT MOFETIL IN THE TREATMENT OF REFRACTORY ADULT CHRONIC IMMUNE THROMBOCYTOPENIC PURPURA |
Milica Colovic
|
Archivo recibido
|
|
241-P
|
RITUXIMAB IN THE TREATMENT OF PATIENTS WITH REFRACTORY IDIOPATHIC THROMBOCYTOPENIC PURPURA |
Carmen Montes-Gaisan
|
Archivo recibido
|
|
242-P
|
CORTICOSTEROIDS FOR THE TREATMENT OF CHRONIC IDIOPATHIC THROMBOCYTOPENIC PURPURA: PATIENT-PERCEIVED BURDEN |
GlaxoSmithKline
|
Archivo recibido
|
|
247-P
|
EVALUATION OF COMORBIDITY AS PROGNOSTIC VARIABLE IN 419 PATIENTS WITH MYELODYSPLASTIC SYNDROMES: A STUDY OF THE AUSTRIAN MDS WORKING GROUP |
Wolfgang Reinhard Sperr
|
Archivo recibido
|
|
248-P
|
A NOVEL RECURRENT GENETIC ABNORMALITY IN MYELODYSPLASTIC SYNDROMES (MDS): REARRANGEMENTS AND AMPLIFICATIONS OF IER3 |
David Steensma
|
Archivo recibido
|
|
249-P
|
NEW INSIGHTS INTO THE BIOLOGY OF REFRACTORY ANEMIA WITH RING SIDEROBLASTS (RARS) AND IDENTIFICATION OF ERYTHROID G-CSF TARGETS BY GENE EXPRESSION PROFILING |
Maryam Nikpour
|
Archivo recibido
|
|
250-P
|
ABT 737 BCL-2 INHIBITOR TARGETS LEUKEMIC STEM CELLS IN MOUSE MODELS OF MYELOID (PRE)LEUKAEMIA |
Christine Chomienne
|
Archivo recibido
|
|
252-P
|
ALLOGENIC STEM CELL TRANSPLANT IN MDS: RESULTS OF THE SPANISH REGISTRY |
Olga Lopez-Villar
|
Archivo recibido
|
|
257-P
|
EXPRESSION OF P53 OR CYTOPLASMIC NUCLEOPHOSMIN ASSOCIATED WITH INCREASED RISK OF DISEASE PROGRESSION IN MYELODYSPLASTIC SYNDROME WITH ISOLATED DEL(5Q) |
Martin Jadersten
|
Archivo recibido
|
|
258-P
|
DIFFERENT PATTERNS OF TELOMERASE REVERSE TRANSCRIPTASE (HTERT) MRNA VARIANT EXPRESSION PROFILES IN PATIENTS WITH MYELODYSPLASTIC SYNDROMES |
Evgenia Verrou
|
Archivo recibido
|
|
259-P
|
INCREASED FREQUENCY OF REGULATORY T-CELLS IN PATIENTS WITH MYELODYSPLASTIC SYNDROMES |
Claudio Fozza
|
Archivo recibido
|
|
260-P
|
PHOSPHOINOSITIDE-PHOSPHOLIPASE C (PI-PLC) BETA1 AS A TARGET OF EPIGENETIC THERAPY IN MDS PATIENTS |
Matilde Follo
|
Archivo recibido
|
|
261-P
|
HYPOMETHYLATING AGENTS IN MYELODYSPLASTIC SYNDROME SYSTEMATIC REVIEW AND META-ANALYSIS |
Ronit Gurion
|
Archivo recibido
|
|
265-P
|
MESENCHYMAL STEM CELLS FROM 5Q- SYNDROME PATIENTS SHOW INCREASED EXPRESSION OF FGF4, IL32 AND TNFalpha IN COMPARISON TO OTHER MDS |
Carlos Santamaria
|
Archivo recibido
|
|
267-P
|
ISOLATED DEL 20Q DEFINES A SUBGROUP OF MDS PATIENTS WITH LOWER BLAST COUNTS AND MORE FREQUENT THROMBOCYTOPENIA |
Thorsten Braun
|
Archivo recibido
|
|
271-P
|
IDENTIFICATION OF FREQUENT GENOMIC ABNORMALITIES IN ADULT ACUTE MYELOID LEUKEMIA (AML) PATIENTS USING SINGLE NUCLEOTIDE POLYMORPHISM (SNP) ARRAYS |
Ilaria Iacobucci
|
Archivo recibido
|
|
277-P
|
THE AMP-KINASE AGONIST METFORMIN HAS TUMOR SUPPRESSOR ACTIVITY IN ACUTE MYELOID LEUKEMIA |
Alexa Green
|
Archivo recibido
|
|
281-P
|
A MOLECUALR CIRCUITRY COMPRISING MICRORNA-223, C/EBP? AND E2F1 IN GRANULOPOIESIS AND IN ACUTE MYELOID LEUKEMIA |
John Pulikkan
|
Archivo recibido
|
|
283-P
|
RETROVIRAL INTEGRATION MUTAGENESIS IN MICE AS A PLATFORM FOR IDENTIFICATION OF CRITICAL TUMOR SUPPRESSOR GENES IN HUMAN MYELOID DISORDERS |
Beekman
|
Archivo recibido
|
|
289-P
|
GENOME PROFILING OF NORMAL KARYOTYPE AML WITH HIGH DENSITY ARRAY COMPARATIVE GENOME HYBRIDISATION |
Chanalaris A
|
Archivo recibido
|
|
290-P
|
BOTH SEPT2 AND MLL ARE DOWN-REGULATED IN MLL-SEPT2 THERAPY-RELATED MYELOID NEOPLASIA |
Nuno Cerveira
|
Archivo recibido
|
|
291-P
|
METHYLATION ANALYSIS OF THE SNRPN AND MEG3 IMPRINTED GENES IN ACUTE MYELOID LEUKEMIA PATIENTS |
Leonidas Benetatos
|
Archivo recibido
|
|
292-P
|
GENE EXPRESSION PROFILE MIGHT PREDICT PROGNOSIS IN PATIENTS WITH INTERMEDIATE-RISK ACUTE MYELOID LEUKEMIA (AML) LACKING NPM1 AND FLT3 MUTATIONS |
Mireia Camos
|
Archivo recibido
|
|
295-P
|
A HYPOTHETICAL-MATHEMATICAL MODEL OF ACUTE MYELOID LEUKEMIA PATHOGENESIS |
Andrei Cucuianu
|
Archivo recibido
|
|
296-P
|
PROGNOSTIC VALUE OF IMMUNOPHENOTYPE IN AML PATIENTS WITH NPM1 MUTATION |
Navarro
|
Archivo recibido
|
|
297-P
|
FLT3 ANTIGEN EXPRESSION IN ACUTE LEUKAEMIA USING FLOW CYTOMETRY |
Sandra Hassan
|
Archivo recibido
|
|
298-P
|
QUANTITATIVE ASSESSMENT OF WT1 EXPRESSION: A USEFUL TOOL FOR MONITORING MINIMAL RESIDUAL DISEASE IN ACUTE LEUKEMIA PATIENTS |
Federica Salmi
|
Archivo recibido
|
|
300-P
|
CONTINUOUS SEQUENTIAL INFUSION OF FLUDARABINE AND CYTARABINE FOR ELDERLY PATIENTS WITH ACUTE MYELOID LEUKEMIA (AML) SECONDARY TO MYELODYSPLASTIC SYNDROME (MDS) |
Salvatore Palmieri
|
Archivo recibido
|
|
303-P
|
LONG-TERM MOLECULAR COMPLETE REMISSION WITH PULSED ATRA AS SINGLE AGENT IN PML-RAR-ALPHA-POSITIVE ACUTE PROMYELOCYTIC LEUKEMIA |
Vigna Ernesto
|
Archivo recibido
|
|
304-P
|
A LUMINESCENT WHOLE CELL BACTERIAL BIOSENSOR FOR RAPID PRE-SCREENING OF CHEMOTHERAPY EFFICACY |
Elizabeth Anderson
|
Archivo recibido
|
|
305-P
|
INDUCTION INTENSIFIED REGIMENS INCLUDING FLUDARABINE OR GEMTUZUMAB-OZOGAMICIN FOR ACUTE MYELOID LEUKEMIA PATIENTS: COMPARISON BY RESPONSE AND FOLLOW-UP |
papayannidis cristina
|
Archivo recibido
|
|
309-P
|
BODY MASS INDEX IS AN INDEPENDENT PREDICTOR OF DIFFERENTIATION SYNDROME IN PATIENTS WITH ACUTE PROMYELOCYTIC LEUKEMIA |
Jeddi
|
Archivo recibido
|
|
311-P
|
CNS MANIFESTION IN PATIENTS WITH ACUTE MYELOID LEUKEMIA SCHEDULED FOR ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION |
Martin Bommer
|
Archivo recibido
|
|
316-P
|
CD34 OBTAINED FROM HIGH SOKAL RISK CHRONIC MYELOID LEUKEMIA (CML) PATIENTS (PTS) EXPRESSES GENE PROFILES (GEP) SIGNIFICANTLY DIFFERENT FROM CD34 OBTAINED FROM LOW AND INTERMEDIATE SOKAL RISK PATIENTS |
Sandra Durante
|
Archivo recibido
|
|
317-P
|
EVALUATION OF THE PROTEASOMAL EFFECTS OF TYROSINE KINASE INHIBITORS AND BORTEZOMIB IN CHRONIC MYELOID LEUKAEMIA |
Scott McCloskey
|
Archivo recibido
|
|
320-P
|
THE ROLE OF THE FANCONI ANEMIA D2 (FANCD2) PROTEIN IN BCR/ABL-MEDIATED LEUKEMOGENESIS |
Tomasz Stoklosa
|
Archivo recibido
|
|
322-P
|
BOSUTINIB (SKI-606) COOPERATES WITH DASATINIB IN COUNTERACTING GROWTH AND VIABILITY OF CML CELLS CARRYING THE T315I MUTANT OF BCR/ABL |
Karoline Gleixner
|
Archivo recibido
|
|
326-P
|
CCN3, A NOVEL PRO-APOPTOTIC FACTOR FOR CHRONIC MYELOID LEUKAEMIA |
Lynn McCallum
|
Archivo recibido
|
|
327-P
|
3-DEAZANEPLANOCIN A (DZNEP) ACTIVITY AGAINST CD34 LEUKAEMIA STEM CELLS |
Svetlana Myssina
|
Archivo recibido
|
|
329-P
|
HETEROGENEOUS MECHANISMS AT THE BASIS OF 5BCR/3ABL FUSION GENE GENERATION IN CHRONIC MYELOID LEUKEMIA |
Francesco Albano
|
Archivo recibido
|
|
331-P
|
E T315I MUTATION CONFERS RESISTANCE AGAINST SMALL MOLECULES BY RESTORING THE ABL-KINASE ACTIVITY ACCOMPANIED BY TRANSPHOSPHORYLATION OF ENDOGENOUS BCR, EVEN IN LOSS-OF-FUNCTION MUTANTS OF BCR/ABL |
Martin Ruthardt
|
Archivo recibido
|
|
333-P
|
AN APPROACH TO OVERCOME BCR-ABL INDEPENDENT STI571 RESISTANCE IN CML |
Esther Rabizadeh
|
Archivo recibido
|
|
335-P
|
DELTA EX6, THE NOVEL TRANSACTIVATION-DEFECTIVE SPLICING VARIANT OF TP53, IS DIFFERENTIALLY EXPRESSED IN PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA AND CONFERS ACCENTED PROLIFERATIVE PHENOTYPE IN VITRO |
Oldrich Mazal
|
Archivo recibido
|
|
337-P
|
INTEGRATIVE HIGH-RESOLUTION MICROARRAYS APPROACH IN B-CELL CHRONIC LYMPHOCYTIC LEUKEMIA REVEALS THE PRESENCE OF MOLECULARLY DISTINCT SUBGROUPS IN PATIENTS WITH 13Q DELETION |
Laura Mosca
|
Archivo recibido
|
|
340-P
|
THE FREQUENCY OF CIRCULATING CLL-LIKE B-CELL CLONES IN OTHERWISE HEALTHY INDIVIDUALS SIGNIFICANTLY INCREASES USING A HIGH-SENSITIVE MULTICOLOR FLOW CYTOMETRY APPROACH |
Wendy
|
Archivo recibido
|
|
342-P
|
GENOME-WIDE DNA COPY NUMBER ANALYSIS BY SNP ARRAYS OF B-CELL CHRONIC LYMPHOCYTIC LEUKEMIA REVEALS THE PRESENCE OF NOVEL MOLECULAR LESIONS |
Laura Mosca
|
Archivo recibido
|
|
343-P
|
THE SYK INHIBITOR R406 BLOCKS BCR SIGNALING, CELL ADHESION AND MIGRATION, AND INDUCES APOPTOSIS IN CLL CELLS: AN EXPLANATION FOR THE CLINICAL ACTIVITY OF R406 IN CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) |
Jan Burger
|
Archivo recibido
|
|
348-P
|
HIGH-RESOLUTION MICROARRAY CHARACTERIZATION OF THE 13Q14 DELETION EXTENT IN B-CELL CHRONIC LYMPHOCYTIC LEUKEMIA: CORRELATION WITH COPY NUMBER AND EXPRESSION LEVELS OF MIR-15A/16-1 CLUSTER |
Laura Mosca
|
Archivo recibido
|
|
349-P
|
MICRORNA-29C AND 223 AND THEIR PROGNOSTIC VALUE IN CHRONIC LYMPHOCYTIC LEUKEMIA |
Basile Stamatopoulos
|
Archivo recibido
|
|
353-P
|
FINAL RESULTS OF ORAL FLUDARABINE WITH CONCOMITANT SUBCUTANEOUS ALEMTUZUMAB IN RELAPSED/REFRACTORY B-CHRONIC LYMPHOCYTIC LEUKAEMIA (B-CLL): THE FLUSALEM STUDY |
Alexander Egle
|
Archivo recibido
|
|
354-P
|
LARGE BUT NOT SMALL COPY-NUMBER ALTERATIONS CORRELATE TO HIGH-RISK GENOMIC ABERRATIONS AND SURVIVAL IN CHRONIC LYMPHOCYTIC LEUKEMIA: A HIGH-RESOLUTION GENOMIC SCREENING IN NEWLY DIAGNOSED PATIENTS |
Rebeqa Gunnarsson
|
Archivo recibido
|
|
356-P
|
EXPRESSION OF MUTATED IGHV3-23 GENES HAS INDEPENDENT PROGNOSTIC RELEVANCE IN CHRONIC LYMPHOCYTIC LEUKEMIA AND IDENTIFIES A DISEASE SUBSET WITH PECULIAR MOLECULAR AND BIOLOGICAL FEATURES |
Riccardo Bomben
|
Archivo recibido
|
|
359-P
|
UPDATE OF THE FRENCH LGL PROLIFERATION REGISTRY: REPORT OF 229 CASES |
Bareau B
|
Archivo recibido
|
|
360-P
|
MONOCLONAL B-CELL LYMPHOCYTOSIS (MBL) IN FIRST-DEGREE RELATIVES OF PATIENTS WITH SPORADIC (NON-FAMILIAL) CHRONIC LYMPHOCYTIC LEUKEMIA |
Daniel Mazza Matos
|
Archivo recibido
|
|
361-P
|
NCRN CLL207 STUDY OF ALEMTUZUMAB CONSOLIDATION IN CLL: REPORT OF THE PLANNED STAGE I ANALYSIS |
Peter Hillmen
|
Archivo recibido
|
|
363-P
|
LENALIDOMIDE INDUCED UPREGULATION OF CD80 ON LEUKEMIC CELLS CORRELATES WITH T-CELL ACTIVATION, THE RAPID ONSET OF A CYTOKINE RELEASE SYNDROME AND CLEARANCE OF TUMOR CELLS IN CHRONIC LYMPHOCYTIC LEUKEMIA |
Adrian Wiestner
|
Archivo recibido
|
|
364-P
|
STANDARD AND REDUCED INTENSITY ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATIONS (HSCT) FROM RELATED AND UNRELATED DONORS FOR CHRONIC LYMPHOCYTIC LEUKEMIA (CLL). A LONG-TERM FOLLOW-UP (10 YEARS) STUDY FROM THE EBMT REGISTRY |
Mauricette Michallet
|
Archivo recibido
|
|
365-P
|
INCREASED EXPRESSION OF MACROPHAGE INFLAMMATORY PROTEIN-1 ALPHA ON TREPHINE BIOPSIES CORRELATES WITH ADVANCED MYELOMA, EXTENSIVE BONE DISEASE AND ELEVATED MICROVESSEL DENSITY IN NEWLY DIAGNOSED PATIENTS WITH MULTIPLE MYELOMA |
Christoulas Dimitrios
|
Archivo recibido
|
|
367-P
|
MICRORNAS AS KEY REGULATORS OF MULTIPLE MYELOMA CELL GROWTH |
Aldo Roccaro
|
Archivo recibido
|
|
368-P
|
LENALIDOMIDE INDUCED P27 KIP1-ASSOCIATED GROWTH ARREST IN MYELOMA CELLS THROUGH DOWN-REGULATION OF BOTH C-MYC AND SCFSKP2 UBIQUITIN LIGASE |
Amiot
|
Archivo recibido
|
|
372-P
|
A NOVEL FISH-BASED NORMALIZATION PROCEDURE FOR WHOLE GENOME MICROARRAYS DETECTING ACCURATE LOCAL COPY NUMBERS: APPLICATION TO MULTIPLE MYELOMA |
Luca Agnelli
|
Archivo recibido
|
|
374-P
|
CORRELATIONS BETWEEN ANGIOGENESIS, MIP-1 ALPHA EXPRESSION BY MALIGNANT CELLS AND MACROPHAGE COUNTS IN WALDENSTROMS MACROGLOBULINEMIA: IMPLICATIONS INTO THE BIOLOGY OF THE DISEASE |
Christoulas Dimitrios
|
Archivo recibido
|
|
375-P
|
ABNORMAL SERUM FREE-LIGHT CHAIN RATIO IN PATIENTS WITH MULTIPLE MYELOMA IN LONG-LASTING COMPLETE REMISSION: STRONG ASSOCIATION WITH OLIGOCLONAL BANDS |
Carlos Fernández de Larrea
|
Archivo recibido
|
|
377-P
|
PTEN IS DOWN REGULATED IN MULTIPLE MYELOMA |
Giovanna Piras
|
Archivo recibido
|
|
378-P
|
DIFFUSE MRI PATTERN CORRELATES WITH INCREASED ANGIOGENESIS, EXTENSIVE BONE DISEASE AND POOR PROGNOSIS IN NEWLY-DIAGNOSED, PRIOR-UNTREATED, PATIENTS WITH MULTIPLE MYELOMA |
Christoulas Dimitrios
|
Archivo recibido
|
|
380-P
|
BUSULPHAN PLUS MELPHALAN (BUMEL) VERSUS MELPHALAN-200 MG (MEL) AS CONDITIONING REGIMENS FOR MULTIPLE MYELOMA (MM): A SEQUENTIAL PROSPECTIVE COMPARATIVE STUDY OF EFFICACY AND TOXICITY |
Ramón García Sanz
|
Archivo recibido
|
|
386-P
|
THE PRESENCE OF RESIDUAL NORMAL PLASMA CELLS BY MULTIPARAMETER FLOW CYTOMETRY IN THE BONE MARROW OF SYMPTOMATIC MULTIPLE MYELOMA PATIENTS AT DIAGNOSIS IDENTIFIES A GOOD PROGNOSTIC SUBGROUP |
Bruno Paiva
|
Archivo recibido
|
|
389-P
|
BORTEZOMIB , PEGYLATED LIPOSOMAL DOXORUBICIN AND DEXAMETHASONE (B-D-D) AS THERAPY FOR ELDERLY PATIENTS WITH RELAPSED REFRACTORY MULTIPLE MYELOMA: A WEEKLY BORTEZOMIB SCHEDULE REDUCES TOXICITIES MANTAINING THE SAME EFFICACY |
Alessandro Gozzetti
|
Archivo recibido
|
|
391-P
|
PATTERNS OF SURVIVAL AND CAUSES OF DEATH FOLLOWING A DIAGNOSIS OF MONOCLONAL GAMMOPATHY OF UNDETERMINED SIGNIFICANCE (MGUS): A POPULATION-BASED STUDY |
Sigurdur Kristinsson
|
Archivo recibido
|
|
392-P
|
BORTEZOMIB IN COMBINATION WITH DEXAMETHASONE OVERCOMES THE NEED FOR ADDITIONAL CHEMOTHERAPY PRIOR TO HIGH-DOSE THERAPY WITH AUTOTRANSPLANT IN PATIENTS WITH MULTIPLE MYELOMA |
Alessandro Corso
|
Archivo recibido
|
|
393-P
|
SURVIVAL EFFECT OF ERYTHOPOIETIC AGENTS AND VENOUS THROMBOEMBOLISM (VTE) IN MULTIPLE MYELOMA PATIENTS TREATED WITH LENALIDOMIDE AND HIGH-DOSE DEXAMETHASONE |
Maurizio Zangari
|
Archivo recibido
|
|
398-P
|
USE OF MAINTENANCE THERAPY WITH BORTEZOMIB AND DEXAMETHASONE (VD) IN ADVANCED MULTIPLE MYELOMA |
Pregno
|
Archivo recibido
|
|
399-P
|
HALOFUGINONE, AN ORALLY-BIOAVAILABLE AGENT, HAS IN VITRO AND IN VIVO ANTIMYELOMA ACTIVITY, ASSOCIATED WITH UP REGULATION OF C-JUN, JNK, AND P-53, PROAPOPTOTIC PROTEINS |
Merav Leiba
|
Archivo recibido
|
|
401-P
|
QUALITATIVE AND QUANTITATIVE ASSESSMENT OF BONE MARROW INVOLVEMENT IN THE ENTIRE SPECTRUM OF NON-HODGKINS LYMPHOMAS: COMPARISON BETWEEN HISTOLOGY AND FLOW CYTOMETRY IN 572 PATIENTS |
Michele Merli
|
Archivo recibido
|
|
402-P
|
CLIPI: A NEW PROGNOSTIC INDEX FOR INDOLENT CUTANEOUS B-CELL LYMPHOMA PROPOSED BY THE INTERNATIONAL EXTRANODAL LYMPHOMA STUDY GROUP (IELSG 11) |
Michael Mian
|
Archivo recibido
|
|
405-P
|
LNH-PRO-05 STUDY: EXCELLENT CLINICAL AND MOLECULAR RESPONSES IN FLIPI=2 FOLLICULAR LYMPHOMA PATIENTS WITH RITUXIMAB PLUS CVP (BAGLEY) AND 12 WEEKS OF INTERFERON ALFA |
Jimena Cannata-Ortiz
|
Archivo recibido
|
|
406-P
|
POSTTRANSPLANT LYMPHOPROLIFERATIVE DISORDER (PTLD): CHARACTERISTICS AND OUTCOME IN A BELGIAN UNIVERSITY HOSPITAL |
Daan Dierickx
|
Archivo recibido
|
|
408-P
|
CLINICAL SIGNIFICANCE OF THE PRESENCE OF OCCULT CNS INVOLVEMENT ASSESSED BY FLOW CYTOMETRY IN PATIENTS WITH NON HODGKINS LYMPHOMA AT HIGH RISK OF CNS RELAPSE |
Juan-Manuel Sancho
|
Archivo recibido
|
|
409-P
|
A PHASE 2 STUDY OF VORINOSTAT (SUBEROYLANILIDE HYDROXAMIC ACID, SAHA) IN RELAPSED OR REFRACTORY INDOLENT NON-HODGKINS LYMPHOMA. A CALIFORNIA CANCER CONSORTIUM STUDY |
Mark Kirschbaum
|
Archivo recibido
|
|
410-P
|
EARLY EVALUATION OF 18-FDG-POSITRON EMISSION TOMOGRAPHY/COMPUTED TOMOGRAPHY (PET) DOES NOT PREDICT THE OUTCOME IN DIFFUSE LARGE B-CELL LYMPHOMA (DLBCL) PATIENTS TREATED WITH R-CHOP |
Patrizia Pregno
|
Archivo recibido
|
|
411-P
|
ACTIVITY AND SAFETY OF BORTEZOMIB AND RITUXIMAB IN RELAPSED/REFRACTORY INDOLENT NON FOLLICULAR AND MANTLE-CELL NON HODGKIN LYMPHOMA: A PHASE II MULTICENTER STUDY BY INTERGRUPPO ITALIANO LINFOMI |
Patrizia Pregno
|
Archivo recibido
|
|
415-P
|
SPLENECTOMY VERSUS RITUXIMAB IN THE TREATMENT OF SPLENIC MARGINAL ZONE LYMPHOMA (SMZL) |
Christina Kalpadakis
|
Archivo recibido
|
|
417-P
|
18-FLUORO-DEOXYGLUCOSE POSITRON EMISSION TOMOGRAPHY (FDG-PET) IN MANTLE CELL LYMPHOMA (MCL) : INITIAL STAGING AND RESPONSE ASSESSMENT, ON BEHALF OF THE GOELAMS. |
Cyrille Touzeau
|
Archivo recibido
|
|
419-P
|
HISTOLOGIC TRANSFORMATION OF FOLLICULAR LYMPHOMA INTO DIFFUSE LARGE B-CELL LYMPHOMA IN THE IOSI EXPERIENCE |
Annarita Conconi
|
Archivo recibido
|
|
420-P
|
FOLLICULAR LYMPHOMA IN LEUKEMIC PHASE AT DIAGNOSIS: CLINICAL AND BIOLOGICAL FEATURES IN A SERIES OF 24 PATIENTS AND COMPARATIVE ANALYSIS WITH NON-LEUKEMIC PATIENTS |
Lucio Morabito
|
Archivo recibido
|
|
422-P
|
CLINICAL IMPACT OF SIX-COLOR FLOW CYTOMETRY IN LYMPHOPROLIFERATIVE DISORDERS: IDENTIFICATION AND EXTENDED CHARACTERIZATION OF COMPOSITE LYMPHOMAS |
Lorenzo Brunetti
|
Archivo recibido
|
|
423-P
|
LONG-TERM FOLLOW-UP OF TANDEM HIGH-DOSE THERAPY WITH AUTOLOGOUS STEM CELL SUPPORT FOR ADULTS WITH HIGH-RISK AGE-ADJUSTED INTERNATIONAL PROGNOSTIC INDEX AGGRESSIVE NON-HODGKINS LYMPHOMAS: A GOELAMS PILOT STUDY |
Hélène Monjanel
|
Archivo recibido
|
|
424-P
|
RAPID INFUSION OF RITUXIMAB IS WELL TOLERATED AND ENABLES MORE EFFICIENT USE OF HAEMATOLOGY DAY WARD RESOURCES |
Stefan Peinert
|
Archivo recibido
|
|
426-P
|
DOSE-DENSE THERAPY WITH NON-PEGYLATED LIPOSOMAL DOXORUBICIN, CYCLOPHOSPHAMIDE, VINCRISTINE, PREDNISONE AND RITUXIMAB (R-COMP) IS FEASIBLE AND EFFECTIVE IN ELDERLY PATIENTS WITH NEWLY DIAGNOSED AGGRESSIVE B-CELL NON-HODGKIN LYMPHOMA. |
Giuseppe Visani
|
Archivo recibido
|
|
428-P
|
IFOSFAMIDE, EPIRUBICIN, AND ETOPOSIDE (IEV) AS MOBILISATION-THERAPY REGIMEN FOR PATIENTS WITH NON-HODGKIN LYMPHOMA AND HODGKIN DISEASE: COMPARISON WITH OTHER CHEMOTHERAPY BASED MOBILISATION REGIMENS |
Laura Quintana-Paris
|
Archivo recibido
|
|
430-P
|
PHARMACODYNAMIC ANALYSES OF PERIPHERAL BLOOD FROM RELAPSED B-NHL PATIENTS TREATED WITH ANTI-CD19/-CD3 BISPECIFIC BITE ANTIBODY BLINATUMOMAB |
Matthias Klinger
|
Archivo recibido
|
|
431-P
|
SAFETY AND EFFICACY OF BENDAMUSTINE WITH OR WITHOUT RITUXIMAB IN THE TREATMENT OF HEAVILY PRETREATED PATIENTS WITH LYMPHOMA OR CLL. A MULTICENTER RETROSPECTIVE STUDY |
Benedetta Puccini
|
Archivo recibido
|
|
432-P
|
CONTINUOUS, ORAL CYCLOPHOSPHAMIDE AND PREDNISOLONE AS A VALID TREATMENT OPTION FOR PERIPHERAL T CELL LYMPHOMA |
Samantha Ferrari
|
Archivo recibido
|
|
433-P
|
LONG TERM OUTCOME OF HIGH DOSE ARACYTINE, RITUXIMAB, AND DEXAMETHASONE CHEMOTHERAPY FOR AGGRESSIVE MANTLE CELL LYMPHOMA IN ELDERLY PATIENTS |
KOTB
|
Archivo recibido
|
|
437-P
|
PATIENTS REQUIRING INTERRUPTION OF LONG-TERM ORAL ANTICOAGULANT THERAPY: THE ADVANTAGE OF FIXED SUB-THERAPEUTIC DOSES OF LOW-MOLECULAR WEIGHT HEPARIN |
Alessandra Malato
|
Archivo recibido
|
|
441-P
|
SOLUBLE ENDOGLIN AND ITS INTERACTION WITH ADHESION MOLECULES IN PATIENTS WITH THALASSEMIA INTERMEDIA |
Ioannis Papassotiriou
|
Archivo recibido
|
|
446-P
|
HIGHER CIRCULATING ACTIVATED PROTEIN C (APC)/PC AND APC/FACTOR II RATIOS DURING ORAL ANTICOAGULANT THERAPY. INFLUENCE OF THE HAPLOTYPE 1 OF THE ENDOTHELIAL PROTEIN C RECEPTOR GENE |
Francisco España
|
Archivo recibido
|
|
447-P
|
LAC TESTING IN PATIENTS WITH INFLAMMATORY STATUS |
Sofie Schouwers
|
Archivo recibido
|
|
450-P
|
THE RISK OF RECURRENT VENOUS THROMBOEMBOLISM IN PATIENTS WITH MULTIPLE GENETIC THROMBOPHILIC DEFECTS: A COMPARATIVE STUDY |
Khaled Ramadan
|
Archivo recibido
|
|
451-P
|
ADAMTS13 LEVELS IN HIV INFECTED PATIENTS WITH AND WITHOUT TTP |
Philip Badenhorst
|
Archivo recibido
|
|
452-P
|
HIGH AVIDITY ANTICARDIOLIPIN ANTIBODIES ASSOCIATE WITH THROMBOSIS IN PATIENTS WITH ANTHIPHOSPHOLIPID SYNDROME |
giambattista lobreglio
|
Archivo recibido
|
|
453-P
|
THE USE OF INFERIOR VENA CAVAL FILTERS AT A DISTRICT GENERAL HOSPITAL IN THE UNITED KINGDOM |
Neha Bhatnagar
|
Archivo recibido
|
|
454-P
|
IDENTIFICATION OF MUTATIONS IN THE PROTEIN C GENE ASSOCIATED WITH THE RISK OF VENOUS TROMBOSIS |
Francisco España
|
Archivo recibido
|
|
455-P
|
ARE THROMBIN-ACTIVATABLE FIBRINOLYSIS INHIBITOR (TAFI) POLYMORPHISMS DETERMINANTS OF THE TYPE OF ACUTE CORONARY SYNDROME? |
Dolors Tassies
|
Archivo recibido
|
|
456-P
|
ORAL VALGANCICLOVIR AS EARLY PRE-EMPTIVE TREATMENT FOR CMV REACTIVATION AFTER ALLOGENEIC STEM CELL TRANSPLANTATION: A SINGLE CENTER EXPERIENCE IN 45 PATIENTS |
Maria Teresa Lupo Stanghellini
|
Archivo recibido
|
|
458-P
|
ONCE-WEEKLY LIPOSOMAL AMPHOTERICIN B FOR PROPHYLAXIS OF INVASIVE FUNGAL INFECTION AFTER GRAFT VERSUS HOST DISEASE (GVHD) IN ALLOGENEIC HAEMATOPOIETIC STEM CELL TRANSPLANTATION (ALLO-SCT): A COMPARATIVE RETROSPECTIVE MONOCENTER STUDY |
Jean El-Cheikh
|
Archivo recibido
|
|
459-P
|
INVASIVE ASPERGILLOSIS IN ACUTE MYELOID LEUKEMIA:REPORT OF SEIFEM-2008 MULTICENTER SURVEY |
Livio Pagano
|
Archivo recibido
|
|
460-P
|
RAPID DETECTION AND IDENTIFICATION OF PATHOGENS IN HEMATOONCOLOGICAL PATIENTS USING MOLECULAR TECHNIQUES |
Oldrich Mazal
|
Archivo recibido
|
|
461-P
|
COMBINED QUANTITATIVE CMV PCR MONITORING WITH PRE-EMPTIVE ORAL VALGANCLOVIR IS EFFECTIVE IN PREVENTING SYMPTOMATIC CMV INFECTION IN ALLOGENEIC HAEMOPOIETIC TRANSPLANT RECIPIENTS |
Saman Hewamana
|
Archivo recibido
|
|
462-P
|
CANDIDEMIA IN PATIENTS WITH HEMAT0LOGICAL MALIGNANCIES: THE ROLE OF PROPHYLAXIS AND THE IMPORTANCE OF LOCAL EPIDEMIOLOGY IN TREATMENT |
Mariana Bastos Oreiro
|
Archivo recibido
|
|
463-P
|
MANAGEMENT OF FEBRILE NEUTROPENIA EPISODES IN PATIENTS WITH HEMATOLOGICAL MALIGNANCIES BY USING THE MULTINATIONAL ASSOCIATION FOR SUPPORTIVE CARE IN CANCER (MASCC) RISK INDEX |
Aspasia Argyrou
|
Archivo recibido
|
|
464-P
|
SERUM N-TERMINAL PRO-BRAIN NATRIURETIC PEPTIDE IN HAEMATOLOGICAL PATIENTS WITH NEUTROPENIC FEVER: A PROSPECTIVE COMPARISON WITH C-REACTIVE PROTEIN |
Esa Jantunen
|
Archivo recibido
|
|
465-P
|
PALONOSETRON (ALOXI): A SINGLE-CENTER EXPERIENCE IN THE PREVENTION OF EMESIS IN PATIENTS AFFECTED BY HAEMATOLOGICAL MALIGNANCIES |
Andrea Angelo Assanelli
|
Archivo recibido
|
|
466-P
|
PROLONGED FOLLOW-UP OF PATIENTS WITH HEMATOLOGICAL MALIGNANCIES INFECTED BY HBV AND HCV |
Sergei Kulikov
|
Archivo recibido
|
|
467-P
|
COMPARISON BETWEEN FILGASTRIM AND PEG-FILGASTRIM IN REDUCING FEBRILE NEUTROPENIA AND MOBILIZING PBSC IN LYMPHOMA PATIENTS TREATED WITH DHAP OR R-DHAP |
Marta Riva
|
Archivo recibido
|
|
469-P
|
FILGRASTIM DOSE HAS AN IMPACT ON INFECTIOUS COMPLICATIONS IN PATIENTS WITH LYMPHOMA FOLLOWING AUTOLOGOUS STEM CELL TRANSPLANTATION |
Zinaida Peric
|
Archivo recibido
|
|
470-P
|
THE CONTRIBUTION OF NUTRITIONAL STATUS OF CHILDREN WITH MALIGNANCY TO MORBIDITY, MORTALITY AND THERAPY OUTCOMES |
Tamer Hassan
|
Archivo recibido
|
|
556-P
|
THE SOMATOSTATIN RECEPTOR 2 INDUCES A REVERSIBLE NEUTROPHILIC DIFFERENTIATION BLOCK |
Lucila Solernó
|
Archivo recibido
|
|
559-P
|
MACROPHAGES AS NOVEL TARGETS FOR ERYTHROPOIETIN |
Lilach Lifshitz
|
Archivo recibido
|
|
561-P
|
ALTERNATIVE USE OF EXON 1 AND DIFFERENTIAL REGULATION OF EXPRESSION OF DOCK10 ISOFORMS BY INTERLEUKIN-4 |
Antonio Parrado
|
Archivo recibido
|
|
563-P
|
AKT AND PKC AS REGULATORS OF DIFFERENTIATION AND TELOMERASE ACTIVITY IN LEUKEMIC CELLS |
Osamu Yamada
|
Archivo recibido
|
|
565-P
|
COMPARATIVE EFFECT OF FILGRASTIM VS. PEGFILGRASTIM AFTER CHEMOTHERAPY ON HIGH GRADE NON HODGKIN LYMPHOMA |
Elena Magro Mazo
|
Archivo recibido
|
|
566-P
|
AN ERYTHROPOIETIN AND CYCLOPHOSPHAMIDE COMBINATION ADDITIVELY ENHANCES IMMUNOGLOBULIN PRODUCTION IN MICE |
Lilach Lifshitz
|
Archivo recibido
|
|
567-P
|
ATYPICAL WHIM SYNDROME ASSOCIATED WITH GRANULOMATOSIS: REPORT OF TWO CASES |
Anne-Violaine Doncker
|
Archivo recibido
|
|
571-P
|
DEVELOPMENT OF A PERSONALIZED MEDICINE TEST FOR HAEMATOLOGICAL MALIGNANCIES |
Teresa Bennett
|
Archivo recibido
|
|
572-P
|
EFFECTS OF THALIDOMIDE, ROFECOXIB AND CAPTOPRIL ON VASCULAR ENDOTHELIAL GROWTH FACTOR IN EHRLICH ASCITES CARCINOMA |
Mona El-Azab
|
Archivo recibido
|
|
574-P
|
DEVELOPMENT OF A NOVEL METHOD TO EVALUATE THE EFFICACY OF MOLECULAR TARGETED THERAPY IN CHRONIC MYELOGENOUS LEUKEMIA BY BIO-IMAGING SYSTEM |
Takeshi Kondo
|
Archivo recibido
|
|
577-P
|
ANALYSIS, PHARMACOKINETICS AND BIODISTRIBUTION OF THE NEW CDK INHIBITOR-CR8 |
Hatem Hamed Sallam
|
Archivo recibido
|
|
578-P
|
EXPRESSION OF PHOSPHORYLATED HISTONE H2AX AND ITS POTENTIAL TO MODULATE ADRIAMYCIN RESISTANCE IN K562/A02 CELL LINE |
Fen Zhou
|
Archivo recibido
|
|
579-P
|
GENETIC ANALYSIS OF THE SHELTERIN COMPLEX COMPONENTS (POT1, RAP1, TPP1, TRF1 AND TRF2) IN DYSKERATOSIS CONGENITA |
Amanda Walne
|
Archivo recibido
|
|
580-P
|
IMMUNOSUPPRESSIVE THERAPY WITH RABBIT ANTITHYMOCYTE GLOBULIN (R-ATG) MIGHT BE COMPARABLE TO HORSE ANTILYMPHOCYTE GLOBULIN (H-AG) IN CHILDHOOD SEVERE APLASTIC ANEMIA WITHOUT HLA-IDENTICAL SIBLING DONOR |
Dae-Chul Jeong
|
Archivo recibido
|
|
582-P
|
HOME INFUSION OF ECULIZUMAB: A UNIQUE AND INNOVATIVE MODEL OF DRUG DELIVERY TO REDUCE TREATMENT-ASSOCIATED BURDEN AND ENHANCE QUALITY OF LIFE FOR PATIENTS WITH PNH |
Louise Arnold
|
Archivo recibido
|
|
583-P
|
USE OF FLAER-BASED ASSAY OF WHITE BLOOD CELLS (MONOCYTES AND GRANULOCYTES) IN THE PRIMARY SCREENING OF PNH CLONES |
Robert Sutherland
|
Archivo recibido
|
|
584-P
|
EFFECT OF ECULIZIMAB THERAPY ON THROMBOCYTOPENIA IN PATIENTS WITH PAROXYSMAL NOCTURNAL HEMOGLOBINURIA (PNH) |
Ilene Weitz
|
Archivo recibido
|
|
585-P
|
EFFICACY OF THE TERMINAL COMPLEMENT INHIBITOR ECULIZUMAB USED CHRONICALLY IN A PATIENT WITH COLD AGGLUTININ DISEASE (CAD) |
Alexander Rth
|
Archivo recibido
|
|
586-P
|
ANEMIA DURING PEGYLATED INTERFERON-RIBAVIRIN THERAPY RESULTS FROM BOTH INCREASE SUPPRESSION OF ERYTHROID DIFFERENTIATION AND HEMOLYSIS |
Luisa Ronzoni
|
Archivo recibido
|
|
587-P
|
MODIFICATION OF THE STANDARD ECULIZUMAB DOSE TO SUCCESSFULLY MANAGE INTRAVASCULAR HAEMOLYSIS BREAKTHROUGH IN PATIENTS WITH PAROXYSMAL NOCTURNAL HAEMOGLOBINURIA |
Richard Kelly
|
Archivo recibido
|
|
589-P
|
IN VITRO EFFECT OF RIBAVIRIN AND PEGYLATED INTERFERON ON ERYTHROPOIESIS |
Luisa Ronzoni
|
Archivo recibido
|
|
590-P
|
ANTI CD 20 (RITUXIMAB) IN PEDIATRIC AUTOIMMUNE HAEMOLYTIC ANAEMIAS. LONG FOLLOW UP IN A SINGLE CENTRE |
Albert Catala
|
Archivo recibido
|
|
591-P
|
LONG-TERM OUTCOME OF ACQUIRED APLASTIC ANEMIA: COMPARATION BETWEEN IMMUNOSUPPRESSIVE THERAPY AND BONE MARROW TRANSPLANTATION |
Ljiljana Tukic
|
Archivo recibido
|
|
592-P
|
THALASSEMIA INTERMEDIA: AN EGYPTIAN EXPERIENCE |
Azza Tantawy
|
Archivo recibido
|
|
593-P
|
SUCCESSFUL TREATMENT OF COMPLEMENT MEDIATED REFRACTORY HAEMOLYSIS ASSOCIATED WITH COLD AND WARM AUTOANTIBODIES USING ECULIZUMAB |
Martin Bommer
|
Archivo recibido
|
|
595-P
|
OSTEOPROTEGERIN AND RECEPTOR ACTIVATOR OF THE NF-KB LIGAND (RANKL) IN EGYPTIAN PATIENTS WITH THALASSEMIA-INDUCED OSTEOPOROSIS |
Alaa El Din Saad Abd El Hamid
|
Archivo recibido
|
|
596-P
|
A CHILD WITH DYSKERATOSIS CONGENITA AND RECENTLY DESCRIBED TINF2 MUTATION |
Nazan Sarper
|
Archivo recibido
|
|
598-P
|
TAFI (THROMBIN ACTIVATABLE FIBRINOLYSIS INHIBITOR) AS A MARKER OF HEMOSTATIC ALTERATION IN PATIENTS WITH BETA-THALASSEMIA |
Randa Matter
|
Archivo recibido
|
|
599-P
|
NAMPT IS ESSENTIAL FOR THE G-CSFINDUCED MYELOID DIFFERENTIATION |
Dan Lan
|
Archivo recibido
|
|
600-P
|
REGULATION OF GRANULOPOIESIS BY NAMPT / NAD / SIRT1 DEPENDENT ACTIVATION OF C/EBP IN PATIENTS SUFFERING FROM SEVERE CONGENITAL NEUTROPENIA (CN) |
Basant Kumar Thakur
|
Archivo recibido
|
|
601-P
|
IS THE RISK OF DEVELOPING AML OR MDS INCREASED IN X-LINKED NEUTROPENIA |
Beel
|
Archivo recibido
|
|
602-P
|
STUDY OF THE QUANTITATIVE AND FUNCTIONAL CHARACTERISTICS OF T REGULATORY CELLS IN PATIENTS WITH CHRONIC IDIOPATHIC NEUTROPENIA |
Helen Papadaki
|
Archivo recibido
|
|
603-P
|
ABNORMALITIES OF SERUM IMMUNOGLOBULIN LEVELS IN PATIENTS WITH CHRONIC IDIOPATHIC NEUTROPENIA: RESULTS FROM A COHORT OF 295 PATIENTS |
Helen Papadaki
|
Archivo recibido
|
|
605-P
|
DIFERENTIAL STIMULATION OF MONOCYTIC CELLS RESULTS IN DISTINCT POPULATIONS OF MICROPARTICLES |
Michael Bernimoulin
|
Archivo recibido
|
|
606-P
|
LEUKOPENIA AND WAS GENE MUTATION IN AN INFANT. A CASE REPORT |
Albert Catala
|
Archivo recibido
|
|
608-P
|
CLINICAL CHARACTERISTICS AND TREATMENT OUTCOME OF LANGERHANS CELL HISTIOCYTOSIS: LARGE STUDY OF SINGLE INSTITUTE |
Hyoung Jin Kang
|
Archivo recibido
|
|
613-P
|
PERIPHERAL BLOOD INVOLVEMENT PROVIDES AN IMPORTANT PROGNOSTIC INFORMATION DURING EARLY TIME POINTS OF CHILDHOOD ALL TREATMENT |
Jana Volejnikova
|
Archivo recibido
|
|
614-P
|
AID EXPRESSION IN BCR/ABL POSITIVE ALL IS ASSOCIATED WITH A PECULIAR GENE EXPRESSION PROFILE AND DEREGULATION OF DNA REPAIR AND REPLICATION GENES |
Monica Messina
|
Archivo recibido
|
|
616-P
|
PROGNOSTIC INTEREST OF BIPARAMETRIC CD45-DNA ANALYSIS OF MEDULLAR LYMPHOBLASTS AT DIAGNOSIS IN CHILDHOOD ACUTE LYMPHOBLASTIC LEUKEMIA |
De Carli E.
|
Archivo recibido
|
|
622-P
|
IMMUNOPHENOTYPIC MODULATION IN ACUTE LYMPHOBLASTIC LEUKEMIA WITH POSTIVE MRD AFTER INDUCTION TREATMENT |
Pere Barba
|
Archivo recibido
|
|
623-P
|
ONCOGENIC PIK3CA MUTATIONS ARE ABSENT IN BCR-ABL POSITIVE ACUTE LYMPHOBLASTIC LEUKEMIA (PH ALL) |
Sylvia Wystub
|
Archivo recibido
|
|
624-P
|
PROLIFERATIVE EFFECT OF HUMAN HEMOKININ-1 ON HUMAN PRE-B LYMPHOCYTE CELL LINE REH |
Merle Béral H.
|
Archivo recibido
|
|
634-P
|
RELEASE OF INTRACELLULAR CALCIUM PRIMES CHRONIC MYELOID LEUKAEMIA CELLS FOR TYROSINE KINASE INHIBITOR (TKI)-INDUCED APOPTOSIS |
Sylvia L. Forchap
|
Archivo recibido
|
|
635-P
|
A SHORT (12M) IFNA/IMATINIB COMBINED THERAPY CAN SECURE LONG TERM MAINTENANCE OF IMATINIB INDUCED CYTOGENETIC REMISSION AFTER DISCONTINUATION OF IMATINIB IN CML PATIENTS WITHOUT MOLECULAR REMISSION |
Izhar Hardan
|
Archivo recibido
|
|
637-P
|
A STUDY OF PLASMA LEVELS OF IMATINIB AND ITS BIOACTIVE METABOLITE CGP-74588 REVEALS NO CORRELATION WITH SUBSEQUENT CLINICAL OUTCOME IN IMATINIB-TREATED CHRONIC MYELOID LEUKAEMIA |
Andrea Davies
|
Archivo recibido
|
|
643-P
|
LONG-TERM SURVIVAL OF PATIENTS WITH LATE CHRONIC PHASE PH-POSITIVE CHRONIC MYELOID LEUKEMIA RECEIVING TYROSINE KINASE INHIBITOR THERAPY AFTER INTERFERON FAILURE |
Stakhina O.V.
|
Archivo recibido
|
|
644-P
|
PREGNANCY AMONG THE PATIENTS WITH CHRONIC MYELOID LEUKEMIA ON IMATINIB THERAPY |
Chelysheva E.Y.
|
Archivo recibido
|
|
645-P
|
INCREASED RISK OF LYMPHOID MALIGNANCIES IN PATIENTS WITH PHILADELPHIA CHROMOSOME-NEGATIVE MYELOPROLIFERATIVE NEOPLASMS |
Alessandro Vannucchi
|
Archivo recibido
|
|
647-P
|
REDUCED SURVIVAL IN PATIENTS WITH PRIMARY MYELOFIBROSIS IS PREDICTED BY A LOW BURDEN OF JAK2V617 MUTATED ALLELE |
Vannucchi Alessandro
|
Archivo recibido
|
|
652-P
|
LIVING WITH ESSENTIAL THROMBOCYTHEMIA IN FRANCE: PROSPECTIVE SURVEY ASSESSING DAILY LIFE DISEASE IMPACT IN 245 PATIENTS |
Rey
|
Archivo recibido
|
|
654-P
|
EFFICACY OF LENALIDOMIDE IN PATIENTS WITH MYELOFIBROSIS: SPANISH COMPASSIONATE USE PROGRAM. PRELIMINARY ANALYSIS |
Inmaculada Castillo
|
Archivo recibido
|
|
656-P
|
UK SYSTEMIC MASTOCYTOSIS REGISTRY: ANALYSIS OF DATA ON 71 CASES |
Dr B Myers
|
Archivo recibido
|
|
657-P
|
POLYCYTHEMIA VERA AS A PREDISPOSING FACTOR FOR AORTIC STENOSIS: INCIDENCE AND CORRELATION WITH BLOOD CELLS COUNT AND MUTATIONAL STATUS |
Barone Rita
|
Archivo recibido
|
|
662-P
|
PRESENCE OF JAK2 V617F MUTATION IS A SINGLE STRONG PREDICTOR OF VASCULAR COMPLICATIONS IN PATIENTS WITH MPD |
Miriam Quitt
|
Archivo recibido
|
|
664-P
|
STUDY OF THE RELATION BETWEEN THE TIME COURSE OF THE JAK2V617F ALLELE BURDEN AND THE CLINICAL OUTCOME IN PATIENTS WITH MYELOPROLIFERATIVE NEOPLASMS (MPNS); A SINGLE CENTER STUDY |
Marta Sobas
|
Archivo recibido
|
|
676-P
|
SELECTION OF MARKERS FOR IDENTIFICATION OF DISEASE-SPECIFIC PHENOTYPES FOR DIAGNOSIS AND MONITORING OF B-LYMPHOPROLIFERATIVE DISORDERS BY FLOW CYTOMETRY |
Andy Rawstron
|
Archivo recibido
|
|
677-P
|
MUTATIONAL ANALYSIS OF TP53, PTEN, PIK3CA AND CTNNB1/BETA-CATENIN GENES IN HUMAN HERPESVIRUS 8-ASSOCIATED PRIMARY EFFUSION LYMPHOMA |
Emmanuelle Boulanger
|
Archivo recibido
|
|
679-P
|
DETECTION OF HYPERMETHYLATION OF TUMOR SUPPRESSOR GENES IN OCULAR ADNEXAL LYMPHOMA USING MULTIPLEX LIGATION-DEPENDENT PROBE AMPLIFICATION (MLPA) |
Huan Ma
|
Archivo recibido
|
|
680-P
|
DETECTION OF PLASMACYTOID (PLASMACYTIC) DIFFERENTIATION IN MARGINAL ZONE B CELL LYMPHOMAS (MZL) BY CD138 EXPRESSION |
Christina Kalpadakis
|
Archivo recibido
|
|
682-P
|
EXPRESSION OF CD66ABCE ON TUMOR CELLS IN NON-HODGKIN LYMPHOMAS AND MULTIPLE MYELOMA |
Heidi Mocikova
|
Archivo recibido
|
|
684-P
|
BCL-2, BCL-6 AND MYC REARRANGEMENTS AND CLINICAL OUTCOME OF DIFFUSE LARGE B-CELL LYMPHOMA |
Marta Sobas
|
Archivo recibido
|
|
685-P
|
RHD GENE POLYMORPHISMS IN ALLOIMMUNIZED D-NEGATIVE INDIVIDUALS WITH HIGH RATE OF RACIAL ADMIXTURE |
Jose Orlando Bordin
|
Archivo recibido
|
|
689-P
|
A 10-YEAR LOOK-BACK ON USE OF CRYOPRECIPITATE IN A TERTIARY CARE HOSPITAL |
Ghada Zakout
|
Archivo recibido
|
|
691-P
|
UNDERSTANDING TRANSFUSION OUTCOMES THROUGH CLINICAL REGISTRIES: VALIDATION OF A LINKAGE TECHNIQUE |
Louise Phillips
|
Archivo recibido
|
|
692-P
|
PLASMA EXCHANGE IN PATIENTS WITH TTP/HUS IN A BLOOD TRANSFUSION CENTRE: RETROSPECTIVE STUDY OF 46 CASES |
Taddeg-Michael Alemayehu
|
Archivo recibido
|
|
693-P
|
ALLOIMMUNIZATION TO ERYTHROCYTE ANTIGENS IN TRANSFUSION-DEPENDENT PATIENTS WITH HAEMOGLOBINOPATHIES: AN EXPERIENCE FROM A GREEK BLOOD TRANSFUSION SERVICE |
Parara M
|
Error en el envío
|
|
694-P
|
PLATELET TRANSFUSION THRESHOLD FOR CENTRAL VENOUS CATHETER INSERTION IN ACUTE LEUKEMIAS |
Kornelius Arn
|
Archivo recibido
|
|
696-P
|
CORD BLOOD BANKING: THE CONTRIBUTE OF BLOOD GROUP MOLECULAR GENOTYPING IN UNITS VALIDATION |
Paola Bergamaschi
|
Archivo recibido
|
|
697-P
|
HAEMOLYTIC DISEASE OF THE FETUS/NEWBORN SECONDARY TO ANTI-N/N |
Dr William Gordon
|
Archivo recibido
|
|
698-P
|
TREATMENT OF ORBISAC DERIVED BUFFY COAT PLATELETS WITH THE MIRASOL PATHOGEN REDUCTION TECHNOLOGY AND STORAGE IN ADDITIVE SOLUTION |
Hkon Reikvam
|
Archivo recibido
|
|
699-P
|
INTRAUTERINE TRANSFUSION RESULTS IN PRENATAL ANEMIA |
Carolina Sanchez Ramos
|
Archivo recibido
|
|
700-P
|
PREDEPOSIT AUTOLOGOUS DONATION IN RADICAL PROSTATECTOMY: APHERESIS VS WHOLE BLOOD |
Dr José Antonio García-Erce
|
Archivo recibido
|
|
702-P
|
ROLE OF RITUXIMAB FOR TREATING PATIENTS WITH IDIOPATHIC TTP/HUS WITH OR WITHOUT ADAMTS-13 ANTIBODIES |
Domenica Caramazza
|
Archivo recibido
|
|
703-P
|
THE EFFICACY AND EFFICIENCY PLATELET TRANSFUSION IN BUFFY COAT PLATELET COMPONENTS TREATED OR NOT BY INTERCEPT BLOOD SYSTEM |
Imad Belkaid
|
Archivo recibido
|
|
704-P
|
DATA REVIEW FROM THE PAVIA CORD BLOOD BANK: CORRELATION BETWEEN CORD BLOOD NUCLEATED AND HAEMATOPOIETIC STEM CELL COUNT AND BIRTHWEIGHT |
Paola Bergamaschi
|
Archivo recibido
|
|
705-P
|
HIGHER IRON SUCROSE DOSE IN A AMBULATORY ANAEMIA TREATMENT PROGRAM |
Dr José Antonio García-Erce
|
Archivo recibido
|
|
708-P
|
STEM CELL TRANSPLANTATION IN DIAMOND-BLACKFAN ANEMIA: A RETROSPECTIVE ANALYSIS |
Kartal M.
|
Archivo recibido
|
|
709-P
|
HLA-E UP-REGULATION ON IFN-G-ACTIVATED AML BLASTS IMPAIRED CD94/NKG2A-DEPENDENT NK CYTOLYSIS FOLLOWING HAPLO-IDENTICAL HAEMATOPOIETIC STEM-CELL TRANSPLANTATION (SCT) |
Nguyen
|
Archivo recibido
|
|
714-P
|
TREATMENT OF MANTLE CELL LYMPHOMA (MCL) BY ALLOGENEIC STEM CELL TRANSPLANTATION A PRELIMINARY REPORT FROM THE TRIALS 060 AND 074 OF THE EAST GERMAN STUDY GROUP FOR HAEMATOLOGY AND ONCOLOGY (OSHO) |
William Krger
|
Archivo recibido
|
|
716-P
|
REDUCED INTENSITY CONDITIONING ALLOGENEIC STEM CELL TRANSPLANTATION DURING APLASIA IN PRIMARY HIGH-RISK AND RELAPSED ACUTE MYELOID LEUKEMIA |
Friedrich Stlzel
|
Archivo recibido
|
|
719-P
|
INTRAVENOUS BUSULFAN IN AUTOLOGOUS STEM CELL TRANSPLANTATION CONDITIONING REGIMEN FOR ADULT PATIENTS WITH ACUTE MYELOID LEUKEMIA. MULTICENTRE RETROSPECTIVE ANALYSIS |
Carlos Grande
|
Archivo recibido
|
|
720-P
|
HIGHER INFUSED CD34 HEMATOPOIETIC STEM CELL DOSE CORRELATES WITH EARLIER LYMPHOCYTE RECOVERY AND BETTER CLINICAL OUTCOME AFTER AUTOLOGOUS STEM CELL TRANSPLANTATION IN NON-HODGKINS LYMPHOMA |
Dok Hyun Yoon
|
Archivo recibido
|
|
721-P
|
SEARCH OF AN UNRELATED DONOR FOR PATIENTS WITH HIGH RISK ACUTE LYMPHOBLASTIC LEUKEMIA: RESULTS OF A PROSPECTIVE, UNICENTRIC STUDY |
Anna Paola Iori
|
Archivo recibido
|
|
722-P
|
SINGLE CENTER COMPARATIVE STUDY OF UNRELATED UMBILICAL CORD BLOOD TRANSPLANTATION VERSUS HLA MATCHED FAMILY DONOR TRANSPLANTATION IN ADULTS WITH ACUTE LEUKEMIA AND HIGH RISK MYELODISPLASTIC SYNDROME |
Isabel Vicuña
|
Archivo recibido
|
|
723-P
|
SECOND ALLOGENEIC STEM CELL TRANSPLANTATION AS SALVAGE TREATMENT IN RELAPSED HAEMATOLOGICAL MALIGNANCIES: FEASIBILITY AND OUTCOME IN 26 PATIENTS |
Maria Teresa Lupo Stanghellini
|
Archivo recibido
|
|
725-P
|
TANDEM AUTO-SCT AND REDUCED-INTENSITY CONDITIONING (RIC) ALLO-SCT FOR RELAPSED OR TRANSFORMED AGGRESSIVE B CELL NON-HODGKINS LYMPHOMA (NHL) |
Clavert
|
Archivo recibido
|
|
727-P
|
SMALL HUMAN -DEFENSIN-3 DERIVED PEPTIDE INDUCES RAPID AND PREFERENTIAL MOBILIZATION OF MOUSE HEMATOPOIETIC PROGENITOR CELLS VIA SDF-1 SECRETION |
Kalinkovich
|
Archivo recibido
|
|
729-P
|
HUMAN MESENCHYMAL STEM CELLS CAN AMELIORATE HEMATOPOIETIC FUNCTION AFTER CHEMO-RADIOTHERAPY INDUCED STROMAL DAMAGE |
S Carrancio
|
Archivo recibido
|
|
730-P
|
CXCL12 RS1801157 POLIMORPHISM IS ASSOCIATED WITH DECREASED MRNA CXCL12 EXPRESSION AND HIGHER HEMOPOIETIC PROGENITOR CELL (HPC) MOBILIZATION |
Beatriz Martín Antonio
|
Archivo recibido
|
|
731-P
|
REPORT OF 15-YEAR EXPERIENCE OF THE MILANO CORD BLOOD BANK: CLINICAL OUTCOMES OF SINGLE UNRELATED CORD BLOOD TRANSPLANTS |
Annalisa Ruggeri
|
Archivo recibido
|
|
733-P
|
FREEZE-DRYING OF HUMAN UMBILICAL CORD BLOOD MONONUCLEAR CELLS |
Yehudit NAtan
|
Archivo recibido
|
|
734-P
|
IMPACT OF VITAMIN D RECEPTOR GENE POLYMORPHISMS ON CLINICAL OUTCOMES OF SIBLING HLA-MATCHED HEMATOPOIETIC STEM CELL TRANSPLANTATION |
Hyeon Jin Cho
|
Archivo recibido
|
|
736-P
|
THE EFFECT OF HUMAN UMBILICAL CORD BLOOD CD34 PROGENITOR CELLS TRANSPLANTATION ON DIABETIC MICE |
fadia Attia
|
Archivo recibido
|
|
740-P
|
AXP IN ROUTINE CORD BLOOD BANKING: CRITICAL ANALYSIS OF DIFFERENT VOLUME REDUCTION METHODOLOGIES |
Pilar Solves
|
Archivo recibido
|
|
741-P
|
PLATELET ENGRAFTMENT IN PATIENTS WITH HEMATOLOGICAL MALIGNANCIES FOLLOWING UNMANIPULATED HAPLOIDENTICAL BLOOD AND MARROW TRANSPLANTATION: EFFECTS OF CD34 CELL DOSE AND DISEASE STATUS |
Feng-Rong Wang
|
Archivo recibido
|
|
742-P
|
A VON WILLEBRAND FACTOR INHIBITORY ANTIBODY EFFECTIVELY INHIBITS ARTERIAL THROMBOSIS IN A HIGH SHEAR RATE MODEL IN BABOONS |
Walter Rensburg
|
Archivo recibido
|
|
746-P
|
PRECLINICAL EXPERIENCES WITH THE NOVEL CALICHEAMICIN-CONJUGATED CD22 ANTIBODY INOTUZUMAB OZOGAMICIN (CMC-544) IN THE TREATMENT OF PEDIATRIC ACUTE LYMPHOBLASTIC LEUKEMIA |
Jeltje de Vries
|
Archivo recibido
|
|
748-P
|
HEAT SHOCK PROTEIN 32-TARGETING DRUGS INDUCE GROWTH ARREST AND APOPTOSIS IN LEUKEMIC CELLS IN ACUTE LYMPHOBLASTIC LEUKEMIA (ALL) |
Renata A. Meyer
|
Archivo recibido
|
|
749-P
|
PROTEOMIC ANALYSIS OF PKC-BETA INHIBITOR ENZASTAURIN-TREATED MANTLE CELL LYMPHOMA |
Marc Weinkauf
|
Archivo recibido
|
|
750-P
|
THE BH3 MIMETIC GX015-070 (OBATOCLAX) INDUCES APOPTOSIS AND GROWTH INHIBITION IN NEOPLASTIC MAST CELLS |
Barbara Peter
|
Archivo recibido
|
|
751-P
|
QUANTITATIVE MEASUREMENT OF NUCLEAR TRANSLOCATION OF NF-?B AND STAT-3 AS PARAMETER OF RESPONSE TO TARGETED TREATMENTS IN IMMUNOPHENOTYPICALLY DEFINED CELLS IN ACUTE MYELOID LEUKEMIA |
Kieran Oloughlin
|
Archivo recibido
|
|
757-P
|
LEUKEMIA CELL-SELECTIVE UPTAKE OF CYTARABINE AND DAUNORUBICIN IN THE BONE MARROW COMPARTMENT MEDIATED BY CPX-351 LIPOSOME INJECTION |
Lawrence Mayer
|
Archivo recibido
|
|
758-P
|
INDUCTION OF APOPTOSIS IN CHRONIC LYMPHOCYTIC LEUCEMIA (CLL) CELLS BY THE PARA-ISOMER OF NITRIC OXIDE-DONATING ACETYLSALICYLIC ACID (P-NO-ASA) AT LOW MICROMOLAR CONCENTRATIONS |
Regina Razavi
|
Archivo recibido
|
|
759-P
|
ZALYPSIS, A NOVEL AND SELECTIVE ANTILEUKEMIC AGENT TARGETING INMATURE BLAST CELL POPULATIONS |
Enrique Colado
|
Archivo recibido
|
|
764-P
|
FLUCTUATION OF CYSTATIN C CONCENTRATION DURING DEFERASIROX TREATMENT IN THALASSEMIC PATIENTS MAY REFLECT HEMODYNAMIC CHANGES |
Ioannis Papassotiriou
|
Archivo recibido
|
|
765-P
|
MALE AND FEMALE FERTILITY AND PREGNANCY IN THALASSAEMIA MAJOR, THE WHITTINGTON EXPERIENCE |
Sneha Muthalali
|
Archivo recibido
|
|
768-P
|
CREATING A EUROPEAN NETWORK OF EXPERT CENTRES ON RARE ANAEMIAS: A NEW CHALLENGE FOR ENERCA 3 |
Joan Lluis Vives Corrons
|
Archivo recibido
|
|
769-P
|
BILIRUBIN LEVELS AND TATA BOX POLYMORPHISM OF UGT1A1 GENE ASSOCIATED TO GILBERTS SYNDROME IN THE DIFFERENT CLINICAL FORMS OF HEREDITARY SPHEROCYTOSIS |
Susana Rocha
|
Archivo recibido
|
|
770-P
|
CARDIAC IRON OVERLOAD AFTER TREATMENT WITH ANTHRACYCLINES IS MODULATED BY HFE GENOTYPE |
Almudena Cascales
|
Archivo recibido
|
|
774-P
|
OXIDATIVE STRESS AND GENE EXPRESSION OF INFLAMMATORY MEDIATORS IN MONONUCLEAR CELLS IN SICKLE CELL DISEASE |
Kleber Fertrin
|
Archivo recibido
|
|
775-P
|
ACUTE HUMAN PARVOVIRUS B19 INFECTION AND NEPHROTIC SYNDROME IN PATIENTS WITH SICKLE CELL DISEASE |
Lynn QuekContact
|
Archivo recibido
|
|
777-P
|
C-TERMINAL DELETION IN THE ALAS2 GENE AND X-LINKED DOMINANT PROTOPORPHYRIA |
Elena Di Pierro
|
Archivo recibido
|
|
778-P
|
ACCURACY OF PLATELET COUNTING BY HAEMATOLOGY ANALYSERS AND ITS POTENTIAL IMPACT ON THE TRANSFUSION DECISION-MAKING PROCESS |
Montserrat Lopez Rubio
|
Archivo recibido
|
|
780-P
|
AUDIT ASSESSING POSSIBLE RISK FACTORS FOR THROMBOTIC MICROANGIOPATHIES IN A SINGLE CLINICAL APHERESIS UNIT |
Jamie Catlow
|
Archivo recibido
|
|
782-P
|
PLATELET MICROPARTICLES IN PEDIATRIC IMMUNE THROMBOCYTOPENIC PURPURA |
azza tantawy
|
Archivo recibido
|
|
783-P
|
INCREASED LEVELS OF PLATELET-LEUCOCYTE COMPLEXES IN BEHCETS DISEASE PATIENTS WITH MAJOR VASCULAR INVOLVEMENT |
Glsm Emel Pamuk
|
Archivo recibido
|
|
784-P
|
HELICOBACTER PYLORI ERADICATION IMPROVES PLATELET COUNT IN INFECTED CHILDREN WITH CHRONIC IDIOPATHIC THROMBOCYTOPENIC PURPURA |
Mara Ferrara
|
Archivo recibido
|
|
785-P
|
DOES ANTI-TNF THERAPY CAUSE ANY CHANGE IN PLATELET ACTIVATION IN ANKYLOSING SPONDYLITIS PATIENTS? |
Gulsum Emel Pamuk
|
Archivo recibido
|
|
787-P
|
ABNORMAL HEPATOBILIARY LABORATORY VALUES AMONG PATIENTS WITH IDIOPATHIC THROMBOCYTOPENIC PURPURA (ITP) |
GlaxoSmithKline
|
Archivo recibido
|
|
788-P
|
CHRONIC AND RECURRENT IDIOPATHIC THROMBOCYTOPENIC PURPURA IN CHILDHOOD SINGLE INSTITUTION EXPERIENCE |
Kata Martinova
|
Archivo recibido
|
|
789-P
|
ITP AND CELIAC DISEASE: A NON SPORADIC ASSOCIATION |
CECERE F
|
Archivo recibido
|
|
790-P
|
CLINICAL AND RADIOLOGIC EVALUATION OF CYTOMEGALOVIRUS-INDUCED THROMBOCYTOPENIA IN INFANTS BETWEEN 1 MONTH AND 6 MONTHS OF AGE |
Sun Young Kim
|
Archivo recibido
|
|
791-P
|
NATIONAL SURVEY ON PREVALENCE AND TREATMENT OF IMMUNE THOMBOCYTOPENIC PURPURA IN POLAND PLATE QUESTIONNAIRE |
Krystyna Zawilska
|
Archivo recibido
|
|
793-P
|
PROMOTER HYPERMETHYLATION STATUS OF THE MEG3 AND SNRPN IMPRINTED GENES IN MYELODYSPLASTIC SYNDROMES |
Leonidas Benetatos
|
Archivo recibido
|
|
794-P
|
SERUM ERYTHROPOIETIN AT DIAGNOSIS IN LOW GRADE MYELODYSPLASTIC SYNDROME CORRELATES WITH BOTH RED CELL ZINC PROTOPORPHYRIN AND SERUM LDH AND MAY REFLECT SEVERITY OF INEFFECTIVE ERYTHROPOIESIS |
philip murphy
|
Archivo recibido
|
|
798-P
|
COMPARISON OF ALTERNATIVE SPLICING OF THE RETROVIRAL RECEPTOR/HEME EXPORTER FLVCR1 IN MYELODYSPLASTIC SYNDROMES AND NORMAL ERYTHROPOIESIS WITH DIAMOND BLACKFAN ANEMIA |
Steensma
|
Archivo recibido
|
|
804-P
|
EXPRESSION PATTERNS OF CELL CYCLE AND DNA REPLICATION GENES DISCRIMINATE EARLY AND ADVANCED MDS |
Alzbeta Vasikova
|
Archivo recibido
|
|
805-P
|
LEUKEMIC TRANSFORMATION OF MDS PATIENTS DYSPLAYING ABNORMAL CYTOGENTICS WITHOUT DEFINITE DYSPLASIA IN BONE MARROW CELLS |
Sung-Yong Kim
|
Archivo recibido
|
|
810-P
|
DIFFERENCES IN EXPRESSION OF GENES INVOLVED IN NUCLEAR FACTOR KAPPA B(NFKB) PATHWAY AFTER ANALYSIS BY QUANTITATIVE POLYMERASE CHAIN REACTION ARRAYS IN MYELODYSPLASTIC SYNDROMES (MDS) PATIENTS |
Rouka Erasmia
|
Archivo recibido
|
|
811-P
|
INFLUENCE OF SERUM FERRITIN LEVELS ON OVERALL SURVIVAL IN PATIENTS WITH MYELODISPLASTIC SYNDROME |
Andrés Jerez
|
Archivo recibido
|
|
812-P
|
PHOSPHOINOSITIDE-PHOSPHOLIPASE C (PI-PLC) BETA1 SIGNALLING IS INVOLVED IN ERYTHROPOIETIN RESPONSE OF LOW RISK MDS PATIENTS |
Carlo Finelli
|
Archivo recibido
|
|
820-P
|
CUP-LIKE ACUTE MYELOID LEUKEMIA: A REPORT FROM A SINGLE CENTER |
Elpiniki Griva-Kritikou
|
Archivo recibido
|
|
821-P
|
DEFINING T(15;17)(Q22;21) TRANSLOCATION MECHANISM IN THERAPY RELATED AND DE NOVO ACUTE PROMYELOCYTIC LEUKEMIA |
Syed Khizer Hasan
|
Archivo recibido
|
|
823-P
|
ANGIOGENESIS IN ACUTE PROMYELOCYTIC LEUKEMIA IS MEDIATED BY THE HEPATOCYTE GROWTH FACTOR |
Andreia Aires
|
Archivo recibido
|
|
827-P
|
EXPRESSION OF ANGIOTENSIN-CONVERTING ENZYME (ACE, CD143) AND SHAPERONS (BIP, CALNEXIN, CALRETICULIN) BY LEUKEMIC DENRITIC CELLS IN ACUTE MYELOID LEUKEMIA (AML) PATIENTS |
Irina Galtseva
|
Archivo recibido
|
|
831-P
|
COMBINATION OF IDARUBICIN, HIGH DOSE CYTARABINE AND SORAFENIB IS HIGHLY EFFECTIVE IN ACHIEVING REMISSION IN NEWLY DIAGNOSED, FLT3-MUTATED ACUTE MYELOID LEUKEMIA (AML) |
Farhad Ravandi
|
Archivo recibido
|
|
833-P
|
PROLONGED EXPOSURE TO LINTUZUMAB MONOTHERAPY IN ACUTE MYELOID LEUKEMIA AND MYELODYSPLASTIC SYNDROMES RESULTS OF A PHASE 1 TRIAL |
Azra Raza
|
Archivo recibido
|
|
838-P
|
THE COMBINATION OF FLOW-CYTOMETRY MINIMAL RESIDUAL DISEASE ASSESSMENT AND CYTOGENETIC/GENETIC PARAMETERS ALLOWS A PROPER RISK STRATIFICATION OF ADULT AML PATIENTS: IMPLICATION FOR TRANSPLANT CHOICE AND POST CONSOLIDATION THERAPY |
Francesco Buccisano
|
Archivo recibido
|
|
839-P
|
PROGNOSTIC AND PREDICTIVE FACTORS FOR SURVIVAL AFTER COMPLETE REMISSION IN INDUCTION THERAPY OF ACUTE MYELOID LEUKAEMIA |
Markus Pfirrmann
|
Archivo recibido
|
|
843-P
|
IMPACT OF MYELODYSPLASIA-RELATED CHANGES AS DEFINED BY THE 2008 WHO CLASSIFICATION SYSTEM IN ELDERLY PATIENTS WITH ACUTE MYELOID LEUKEMIA (AML) TREATED INTENSIVELY |
gardin
|
Archivo recibido
|
|
848-P
|
IMPACT OF MOLECULAR MARKERS AND CYTOGENETIC ABNORMALITIES ON LONG-TERM OVERALL SURVIVAL AND DISEASE FREE SURVIVAL IN ACUTE MYELOID LEUKEMIA (AML) PATIENTS RECEIVING ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATIONS (HSCT) |
Mauricette Michallet
|
Archivo recibido
|
|
856-P
|
COMPARISON OF HIGH PREFORMANCE LIQUID CHROMATOGRAPHY-ULTRAVIOLET DETECTION (HPLC-UV) VS LIQUID CHROMATOGRAPHY/TANDEM MASS SPECTROMETRY (LC/MS/MS) TO DETERMINE IMATINIB PLASMA LEVELS IN CML-CP PATIENTS |
Dr. Isam Salem (dr.salem@iprc.com.jo)
|
Archivo recibido
|
|
859-P
|
CHRONIC MYELOID LEUKAEMIA PATIENTS WITH THE E13A2 BCR-ABL TRANSCRIPT HAVE INFERIOR RESPONSE TO IMATINIB THAN E14A2 PATIENTS |
Claire Lucas
|
Archivo recibido
|
|
860-P
|
OVERVIEW OF CHRONIC MYELOID LEUKEMIA AND CURRENT DIAGNOSIS AND TREATMENT PATTERNS FROM 15 HOSPITALS IN CHINA |
Ying Wang
|
Archivo recibido
|
|
861-P
|
CHRONIC MYELOID LEUKEMIA AS SECOND MALIGNANCY; A RETROSPECTIVE MULTICENTRIC STUDY |
Emilio Iannitto
|
Archivo recibido
|
|
866-P
|
PROANGIOGENIC CYTOKINES IN CHRONIC MYELOID LEUKEMIA TREATED WITH IMATINIB MESYLATE |
Kostyantyn Kotlyarchuk
|
Archivo recibido
|
|
867-P
|
IMATINIB DOSE ESCALATION FOR CML RESISTANT PATIENTS IS USEFUL IN GENERAL PRACTICE: IMPACT ON CYTOGENETIC REMISSION |
A.Yu Zaritskey
|
Archivo recibido
|
|
871-P
|
JAK2V617F-INDEPENDENT OVEREXPRESSION OF AUTOCRINE/PARACRINE HEPATOCYTE GROWTH FACTOR (HGF) AND/OR INTERLEUKIN-11 (IL-11) IN POLYCYTHEMIA VERA AND INHIBITION OF CLONAL EYTHROID PROGENITOR GROWTH BY BLOCKING THE HGF/IL-11 PATHWAYS |
Hermouet S
|
Archivo recibido
|
|
874-P
|
GENE EXPRESSION PROFILING OF CD34 CELLS IN MYELOPROLIFERATIVE DISORDERS BY CDNA MICROARRAY TECHNOLOGY |
Vladan Cokic
|
Archivo recibido
|
|
875-P
|
THREE NOVEL MUTATIONS IN THE PROLYL HYDROXYLASE DOMAIN PROTEIN 2 GENE OF THE OXYGEN SENSING PATHWAY IN PATIENTS WITH ISOLATED ERYTHROCYTOSIS |
Albiero Elena
|
Archivo recibido
|
|
876-P
|
REACTIVE OXYGEN SPECIES ARE DIFFERENTIALLY REGULATED IN CHRONIC MYELOID LEUKEMIA VERSUS PHILADELPHIA NEGATIVE MYELOPROLIFERATIVE NEOPLASMS |
Estelle Guerin
|
Archivo recibido
|
|
877-P
|
TYROSINE PHOSPHORYLATED SOCS3 IS UNABLE TO REGULATE THE MYELOPROLIFERATIVE NEOPLASM ASSOCIATED- JAK2 V617F KINASE |
Joanne Elliott
|
Archivo recibido
|
|
879-P
|
A NEW PROLYL HYDROXYLASE DOMAIN PROTEIN 2 MUTATION IN A JAK2(V617F) POSITIVE PATIENT WITH A FAMILIAL MYELOPROLIFERATIVE DISEASE |
Albiero Elena
|
Archivo recibido
|
|
880-P
|
SOCS1, SOCS3 AND PTPN6 METHYLATION IN PATIENTS WITH PHILADELPHIA-NEGATIVE CHRONIC MYELOPROLIFERATIVE DISEASES (CMPD) |
Mathilde Fdermayr
|
Archivo recibido
|
|
884-P
|
MURINE MYELOPROLIFERATIVE DISORDER WITH LIVER LESION: CHARACTERISTICS OF LEUKEMIA STEM CELLS AND PHENOTYPE OF CELLS INVADED LIVER |
Alexey Bigildeev
|
Archivo recibido
|
|
885-P
|
EPIGENETIC CHANGES IN JAK2V617F POSITIVE MYELOPROLIFERATIVE DISORDERS |
Antonella Uras
|
Archivo recibido
|
|
886-P
|
PRIMARY MYELOFIBROSIS CD34 CELLS SHOW DIFFERENT CXCR4 CHEMOKINE RECEPTOR PROFILES AT SITES OF DISEASE ACTIVITY |
Margherita Massa
|
Archivo recibido
|
|
887-P
|
IDIOPATHIC HYPEREOSINOPHILIC SYNDROME IN CHILDREN: MOLECULAR ANALYSIS AND CLONAL EVOLUTION |
Maria Cristina Rapanotti
|
Archivo recibido
|
|
891-P
|
SOCS3 TYROSINE PHOSPHORYLATION AS A BIO-MARKER FOR THE MYELOPROLIFERATIVE DISORDER-ASSOCIATED MUTANT JAK2 KINASES |
Krystyna Nahlik
|
Archivo recibido
|
|
894-P
|
POLYCYTHEMIA VERA (PV) BUT NOT ESSENTIAL THROMBOCYTHEMIA (ET) REDUCES THE LIFE EXPECTANCY IN ELDERLY |
Fabiana Tezza
|
Archivo recibido
|
|
896-P
|
THY-1, C-KIT AND TFR EXPRESSIONS ON CD34 MYELOBLASTS IN PATIENTS WITH MYELODYSPLASTIC SYNDROMES AND THEIR RELATIONS TO IPSS |
Maha Atfy
|
Archivo recibido
|
|
897-P
|
LANGERHANS CELL HISTIOCYTOSIS IN CHILDREN - DIAGNOSIS, TREATMENT AND FOLLOW-UP |
Sofijanka Glamocanin
|
Archivo recibido
|
|
898-P
|
THROMBOSIS IN POLYCYTHEMIA VERA (PV) ARE LIKELY TO BE RELATED TO HIGHER JAK2V617F ALLELE BURDEN |
Irene Bertozzi
|
Archivo recibido
|
|
899-P
|
LEUKOCYTOSIS IS A RISK FACTOR FOR RECURRENT THROMBOSIS IN PATIENTS WITH POLYCYTHEMIA VERA AND ESSENTIAL THROMBOCYTHEMIA |
Valerio De Stefano
|
Archivo recibido
|
|
901-P
|
MALDI-TOF MS PROFILING TO EXAMINE THE PROTEIN CONTENT IN B-CELL CHRONIC LYMPHOCYTIC LEUKEMIA |
Bossio Sabrina
|
Archivo recibido
|
|
905-P
|
QUANTITATIVE ANALYSIS OF REPETITIVE ELEMENTS METHYLATION IN B-CELL CHRONIC LYMPHOCYTIC LEUKEMIA |
Sonia Fabris
|
Archivo recibido
|
|
908-P
|
IGVH MUTATION STATUS AND ZAP-70 EXPRESSION AS INDICATORS FOR MOLECULAR PROFILING SIGNATURE IN B-CLL PATIENTS FOR PROGNOSTIC CLASSIFICATION |
Alessandra Trojani
|
Archivo recibido
|
|
911-P
|
IN VITRO CYTOTOXICITY AND ZNF331 ARE RELATED TO RESPONSE AND RELAPSE IN PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) TREATED WITH FLUDARABINE, CYCLOPHOSPHAMIDE AND MITOXANTRONE (FCM) |
Neus Villamor
|
Archivo recibido
|
|
914-P
|
THE DISTRIBUTION OF XRCC1-399 AND XPD-751 GENOTYPES IN CHRONIC LYMPHOCYTIC LEUKEMIA PATIENTS WITH SECONDARY TUMORS AND RICHTER TRANSFORMATION |
Nadiia Bilous
|
Archivo recibido
|
|
920-P
|
MULTICENTER EXTERNAL VALIDATION OF A NOMOGRAM AND A SCORE FOR PREDICTING OVERALL SURVIVAL IN CLL: A STUDY ON 922 PATIENTS |
Bulian Pietro
|
Archivo recibido
|
|
925-P
|
RELATIONSHIP BETWEEN CYTOGENETIC ANOMALIES AND BIOMARKERS IN BINET STAGE A PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA AT DIAGNOSIS: PRELIMINARY RESULTS OF A PROSPECTIVE, MULTICENTER O-CLL1 GISL STUDY |
Sonia Fabris
|
Archivo recibido
|
|
926-P
|
BETA2-MICROGLOBULIN IS A BETTER PREDICTOR OF TREATMENT-FREE SURVIVAL IN PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKAEMIA IF ADJUSTED ACCORDING TO GLOMERULAR FILTRATION RATE |
Julio Delgado
|
Archivo recibido
|
|
930-P
|
HIGH INTRACELLULAR CONTENT OF CYCLIN-DEPENDENT KINASE INHIBITOR P27KIP1 IN EARLY- AND INTERMEDIATE STAGE B-CELL CHRONIC LYMPHOCYTIC LEUKEMIA LYMPHOCYTES PREDICTS RAPID PROGRESSION OF THE DISEASE |
Marcin Wojtowicz
|
Archivo recibido
|
|
931-P
|
ALEMTUZUMAB ADMINISTERED BY SUBCUTANEOUS ROUTE IS LESS EFFECTIVE THAN INTRAVENOUS ROUTE FOR FIRST LINE THERAPY OF T-CELL PROLYMPHOCYTIC LEUKAEMIA: RESULTS OF A PILOT STUDY (UKCLL05) |
Amit Khot
|
Archivo recibido
|
|
932-P
|
INCLUSION OF TOTAL BODY CT SCAN IN THE INITIAL WORK-UP OF CLL PATIENTS WITH EARLY-STAGE ON CLINICAL GROUNDS: PRELIMINARY RESULTS OF A PROSPECTIVE, MULTICENTER O-CLL1- GISL STUDY |
Gentile Massimo
|
Archivo recibido
|
|
934-P
|
AN EXPERIMENTAL STUDY FOR PERIPHERAL NEUROPATHY ASSOCIATED WITH WALDENSTRMS MACROGLOBULINEMIA |
Anastasia Tsingotjidou
|
Archivo recibido
|
|
935-P
|
HGF AND IGF-1 POTENTIATE SDF-1 MEDIATED MYELOMA CELL MIGRATION THROUGH ACTIVATION OF PAK |
Unn-Merete Fagerli
|
Archivo recibido
|
|
936-P
|
SPARC GENE EXPRESSION IN MULTIPLE MYELOMA PATIENTS AND ITS REGULATION BY CYTOTOXIC TREATMENTS IN MYELOMA CELL LINES |
Rajko Kusec
|
Archivo recibido
|
|
937-P
|
GLOBAL MICRORNA EXPRESSION PROFILING IN MULTIPLE MYELOMA IDENTIFIES DEREGULATED PATTERNS ASSOCIATED WITH DISTINCT MOLECULAR GROUPS |
Marta Lionetti
|
Archivo recibido
|
|
940-P
|
CXCR4 AND CD43 CO-EXPRESSION IN PLASMA CELL MALIGNANCIES |
Paola Della Cioppa
|
Archivo recibido
|
|
941-P
|
NOVEL WHOLE CELL ASSAYS TO MONITOR PROTEASOME ACTIVITY IN MULTIPLE MYELOMA |
Andrea Liggett
|
Archivo recibido
|
|
943-P
|
IMMUNOHISTOCHEMICAL EVALUATION OF SARCOGLYCANS AND INTEGRIN IN GINGIVAL EPITHELIUM OF MULTIPLE MYELOMA PATIENTS WITH BISPHOSPHONATE-INDUCED OSTEONECROSIS OF THE JAW |
Allegra Alessandro
|
Archivo recibido
|
|
944-P
|
SEQUENTIAL EVALUATION OF SERUM HEPCIDIN IN ANEMIC MYELOMA PATIENTS: A PILOT STUDY OF CORRELATIONS WITH MYELOMA TREATMENT, DISEASE VARIABLES, AND ANEMIA RESPONSE |
Eirini Katodritou
|
Archivo recibido
|
|
945-P
|
FGFR3 IS EXPRESSED AND IMPORTANT FOR SURVIVAL IN INA-6, A HUMAN MYELOMA CELL LINE WITHOUT A T(4;14) |
Thea Kristin Vtsveen
|
Archivo recibido
|
|
946-P
|
ESTABLISHMENT OF AN INTERLEUKIN-6 INDEPENDENT VARIANT (CMA-03/06) OF THE HUMAN MYELOMA CELL LINE CMA-03: BIOLOGICAL AND MOLECULAR CHARACTERIZATION BY A GENOMIC INTEGRATIVE ANALYSIS |
Donata Verdelli
|
Archivo recibido
|
|
948-P
|
EXPRESSION OF CD27 ON PLASMA CELLS IN MULTIPLE MYELOMA |
Lucie Kovarova
|
Archivo recibido
|
|
950-P
|
CONFIRMATION OF THE UTILITY OF THE IMWG THROMBOPROPHYLAXIS STRATEGY IN MYELOMA PATIENTS RECEIVING THALIDOMIDE; EXPERIENCE OF A LARGE SINGLE CENTRE INSTITUTION |
Neil Rabin
|
Archivo recibido
|
|
953-P
|
EFFICACY OF PAD REGIMEN AS AN INDUCTION THERAPY BEFORE AUTOLOGOUS STEM CELL TRANSPLANTATION IN VAD OR CTD REFRACTORY MYELOMA |
Maria Kraj
|
Archivo recibido
|
|
957-P
|
THALIDOMIDE OR BORTEZOMIB IN COMBINATION WITH DEXAMETHASONE AS SECOND-LINE THERAPY FOR REFRACTORY/RELAPSED MULTIPLE MYELOMA: A COMPARISON OF EFFICACY AND TOXICITY |
Marzia Varettoni
|
Archivo recibido
|
|
958-P
|
INCREASED BONE MINERAL DENSITY IN A SUBSET OF PATIENTS WITH RELAPSED MULTIPLE MYELOMA WHO RECEIVED THE COMBINATION OF BORTEZOMIB, DEXAMETHASONE AND ZOLEDRONIC ACID |
Christoulas Dimitrios
|
Archivo recibido
|
|
961-P
|
18F-FDG-PET UTILITY IN MULTIPLE MYELOMA. NEW DURIE-SALMON PLUS STAGING SYSTEM. OUR EXPERIENCE |
Laura Entrena
|
Archivo recibido
|
|
964-P
|
SERUM DKK1 IN SMOLDERING MULTIPLE MYELOMA |
Jose M. Hernandez Martín
|
Archivo recibido
|
|
966-P
|
BISPHOSPHONATE USE AND OSTEONECROSIS OF THE JAW INCIDENCE IN MULTIPLE MYELOMA PATIENTS IN THE REPUBLIC OF IRELAND |
Johnny McHugh
|
Archivo recibido
|
|
967-P
|
THE ASSOCIATION BETWEEN RESVERATROL WITH SIMVASTATIN DECREASES IGM SECRETION IN WALDENSTROM MACROGLOBULINAEMIA |
Francesco Iuliano
|
Archivo recibido
|
|
969-P
|
EVALUATING THE IMPACT OF RISK CATEGORISATION ON THE MANAGEMENT OF MGUS |
Hasham Almeshhedani
|
Archivo recibido
|
|
971-P
|
IN MANTLE CELL LYMPHOMA (MCL) THE MCL-INTERNATIONAL PROGNOSTIC INDEX (MIPI) IS A BETTER PREDICTOR OF EVENT-FREE AND OVERALL SURVIVAL THAN INTERNATIONAL PROGNOSTIC INDEX (IPI) IN PATIENTS RECEIVING INTENSIVE 1ST LINE TREATMENT INCLUDING ASCT |
Christian Geisler
|
Archivo recibido
|
|
973-P
|
TEMSIROLIMUS FOR THE TREATMENT OF PATIENTS WITH RELAPSED OR REFRACTORY MANTLE CELL LYMPHOMA: SUPPORTIVE EFFICACY ANALYSES FROM THE PHASE 3 STUDY |
Georg Hess
|
Archivo recibido
|
|
976-P
|
POST-TRANSPLANTATION LYMPHOPROLIFERATIVE DISORDER: REDUCTION OF IMMUNOSUPPRESSION AS INITIAL THERAPY. RETROSPECTIVE ANALYSIS OF CLINICAL CHARACTERISTICS AND PROGNOSTIC VARIABLES |
Ran Reshef
|
Archivo recibido
|
|
979-P
|
IMPACT OF TIME-DEPENDENT VARIABLES ON THE OUTCOME OF SPLENIC MARGINAL ZONE LYMPHOMA: A DYNAMIC MODEL ON 84 PATIENTS |
Sara Rattotti
|
Archivo recibido
|
|
981-P
|
MANTLE CELL INTERNATIONAL PROGNOSTIC INDEX (MIPI) AND BIOLOGICAL-MIPI ARE BETTER PREDICTORS OF THE OUTCOME OF MANTLE CELL LYMPHOMA (MCL) PATIENTS THAN IPI: A RETROSPECTIVE ANALYSIS |
Vitolo Umberto
|
Archivo recibido
|
|
984-P
|
CEREBROSPINAL FLUID FLOW CYTOMETRY ANALYSIS IN NEWLY DIAGNOSED AGGRESSIVE NON-HODGKIN LYMPHOMAS AT HIGH RISK FOR LEPTOMENINGEAL DISEASE: A MULTICENTRIC PROSPECTIVE ITALIAN STUDY |
Vitolo
|
Archivo recibido
|
|
985-P
|
EFFICACY AND SAFETY OF LOW-INTENSITY ORAL AND INTRAVENOUS FLUDARABINE-CYCLOPHOSPHAMYDE WITH AND WITHOUT RITUXIMAB FOR FIRST-LINE TREATMENT OF FOLLICULAR LYMPHOMA |
Ana Marin-Niebla
|
Archivo recibido
|
|
986-P
|
A NEW SHORT-TERM HIGH INTENSIVE PROTOCOL BL-M-04 FOR ADULT PATIENTS WITH BURKITT LYMPHOMA: EFFICACY AND TOXICITY |
Elena Baryakh
|
Archivo recibido
|
|
987-P
|
RETROSPECTIVE AND PROSPECTIVE ANALYSIS ON THE IMPACT OF HEPATITIS VIRUSES ON CHRONIC LYMPHOPROLIFERATIVE DISORDERS |
Ana-Maria Vladareanu
|
Archivo recibido
|
|
988-P
|
METHOTREXATE RELATED LYMPHOPROLIFERATIVE DISORDER EXPERIENCE OF A DISTRICT GENERAL HOSPITAL IN THE UK |
Dr Sunil Gupta
|
Archivo recibido
|
|
989-P
|
CHLORAMBUCIL WITH OR WITHOUT RITUXIMAB IS AN EFFECTIVE THERAPY IN NON-GASTRIC MALT LYMPHOMAS |
Christina Kalpadakis
|
Archivo recibido
|
|
992-P
|
FRONT-LINE AUTOLOGOUS PURGED TRANSPLANTATION IN INDOLENT NON-HODGKINS LYMPHOMAS: A LONG-TERM FOLLOW-UP STUDY |
Miguel T. Hernandez
|
Archivo recibido
|
|
993-P
|
FRONT-LINE RISK-ADAPTED IMMUNOCHEMOTHERAPY IMPROVES OUTCOME IN INTERMEDIATE/HIGH-RISK PATIENTS WITH FOLLICULAR LYMPHOMA |
Vit Prochazka
|
Archivo recibido
|
|
994-P
|
THE PROGNOSTIC SIGNIFICANCE OF THE NUMBER OF EXTRANODAL INVOLVEMENT SITES IN THE PATIENTS WITH DISSEMINATED DIFFUSE LARGE B-CELL LYMPHOMA TREATED WITH R-CHOP |
Changhoon Yoo
|
Archivo recibido
|
|
995-P
|
ADDITION OF YTTRIUM-90 IBRITUMOMAB TIUXETAN TO BEAM CONDITIONING PRIOR TO AUTOGRAFTING DOES NOT IMPROVE OUTCOME OF CHEMOREFRACTORY PATIENTS WITH AGGRESSIVE B-CELL NHL |
Igor Aurer
|
Archivo recibido
|
|
996-P
|
A POSSIBLE ROLE OF 18F-FDG PET IN THE EARLY DETECTION OF RITUXIMAB-INDUCED PNEUMONITIS IN PATIENTS WITH NON-HODGKINS LYMPHOMA |
L. Nieuwenhuizen
|
Archivo recibido
|
|
997-P
|
FIRST-LINE TREATMENT WITH RITUXIMAB AND BENDAMUSTINE IN OLD PATIENTS (80 YEARS AND OLDER) WITH AGGRESSIVE B-CELL LYMPHOMAS AN INTERIM ANALYSIS OF AN ONGOING PHASE II STUDY |
Eckhart Weidmann
|
Archivo recibido
|
|
998-P
|
KI-67 EXPRESSION IS PREDICTIVE OF PROGNOSIS IN PATIENTS OF DIFFUSE LARGE B-CELL LYMPHOMA TREATED WITH RITUXIMAB PLUS CHOP |
Dok Hyun Yoon
|
Archivo recibido
|
|
1002-P
|
HAEMATOPATHOLOGY DIAGNOSTIC SKILLS ACQUIRED IN A VIRTUAL LABORATORY: PRACTICAL TEACHING IN THE 21ST CENTURY |
Sheila OConnor
|
Archivo recibido
|
|
1003-P
|
IMMUNOHISTOCHEMICAL DETECTION OF ZAP-70 IN A SERIES OF MARGINAL ZONE LYMPHOMA (MZL) PATIENTS |
Christina Kalpadakis
|
Archivo recibido
|
|
1004-P
|
OUTCOME OF AGGRESSIVE ATL-HTLV1 PATIENTS AFTER CHOP21 AS FIRST LINE TREATMENT - BUCHAREST EXPERIENCE |
Diana Cisleanu
|
Archivo recibido
|
|
1006-P
|
SUBCLINICAL ATHEROSCLEROSIS IN YOUNG ?-THALASSEMIA MAJOR PATIENTS |
azza tantawy
|
Archivo recibido
|
|
1007-P
|
SILICA CLOTTING TIME IN LABORATORY DIAGNOSIS OF LUPUS ANTICOAGULANT (LA). AN USEFUL TOOL FOR DIAGNOSIS OF ANTIPHOSPHOLIPID SYNDROME (APS) IN PATIENTS ON ANTICOAGULANT TREATMENT |
Nuria Fernandez-Mosteirin
|
Archivo recibido
|
|
1008-P
|
POTENTIAL FUNCTION OF EGF1 DOMAIN PEPTIDE IN ANTICOAGULATION THERAPY: BINDING TO TISSUE FACTOR WITHOUT THE ABILITY OF COAGULATION |
Heng Mei
|
Archivo recibido
|
|
1009-P
|
RELATIONSHIP BETWEEN INR MEASURED WITH DIFFERENT THROMBOPLASTINS, COAGULATION FACTOR LEVELS AND THROMBIN GENERATION IN PATIENTS RECEIVING ORAL VITAMIN K ANTAGONISTS |
Devreese Katrien
|
Archivo recibido
|
|
1010-P
|
ENDOTHELIAL KLF4 LINKS PRO-INFLAMMATORY LEVELS TO THE EXPRESSION OF PAI-1 AND VWF GENE |
Lin Hua Yang
|
Archivo recibido
|
|
1015-P
|
A NORMAL D-DIMER VALUE, MEASURED BY A HIGH SENSITIVITY ASSAY, RULE OUT A SUSPECTED VENOUS THROMBOEMBOLISM EPISODE INDEPENDENTLY OF PRETEST CLINICAL PROBABILITY |
Francesc J Casals Sole
|
Archivo recibido
|
|
1016-P
|
ELEVATED LEVELS AND DIFFERENT SUBSETS OF PROCOAGULANT MICROPARTICLES IN BREAST CANCER PATIENTS USING HORMONAL THERAPY |
Muriel van Schilfgaarde
|
Archivo recibido
|
|
1017-P
|
ROLE OF JAK2 MUTATION IN PATIENTS WITH SPLANCHNIC VEIN THROMBOSIS: AIIMS EXPERIENCE |
Shyam Rathi
|
Archivo recibido
|
|
1018-P
|
A TWO YEAR OBSERVATIONAL STUDY OF PATIENTS ATTENDING A DEEP VEIN THROMBOSIS CLINIC-DEMOGRAPHICS, RISK FACTORS AND ANATOMICAL SITE OF THROMBOSIS |
Julie Blundell
|
Archivo recibido
|
|
1019-P
|
THROMBOEMBOLISM PREDICTIVE FACTORS IN POLYCYTHEMIA VERA AND ESSENTIAL THROMBOCYTHEMIA |
Bellora Alessandro
|
Archivo recibido
|
|
1024-P
|
LOW LEVELS OF PROTEIN Z ARE ASSOCIATED WITH HELLP SYNDROME AND ITS SEVERITY |
Isik Kaygusuz
|
Archivo recibido
|
|
1028-P
|
MOLECULAR DIAGNOSIS APPROACH OF BLOOD STREAM INFECTIONS OF THE NEUTROPENIC PATIENT WITH HAEMATOLOGICAL MALIGNANCES |
Giambattista Lobreglio
|
Archivo recibido
|
|
1029-P
|
THE ROLE OF PROPHYLACTIC ANTIMICROBIALS DURING AUTOLOGOUS STEM CELL TRANSPLANTATION : A SINGLE CENTER EXPERIENCE |
Byeong Seok Sohn
|
Archivo recibido
|
|
1030-P
|
EFFECTIVENESS AND SECURITY OF ITRACONAZOL FOR INVASIVE FUNGAL INFECTION (IFI) PRIMARY PROPHYLAXIS IN PATIENTS WITH ACUTE LEUKEMIA |
Consuelo Martinez
|
Archivo recibido
|
|
1031-P
|
PROGNOSTIC FACTORS AND OUTCOME OF PATIENTS ADMITTED TO THE INTENSIVE CARE UNIT (ICU) WITH HEMATOLOGICAL MALIGNANCIES |
Consuelo Martinez
|
Archivo recibido
|
|
1032-P
|
COMPLIANCE TO IDSA-GUIDELINES FOR THE TREATMENT OF INVASIVE ASPERGILLOSIS IN ACUTE MYELOID LEUKEMIA |
Morena Caira
|
Archivo recibido
|
|
1033-P
|
EFFICACY AND SAFETY OF MICAFUNGIN AS AN EMPIRICAL ANTIFUNGAL AGENT FOR FEBRILE NEUTROPENIC PATIENTS |
Joon Seong Park
|
Archivo recibido
|
|
1034-P
|
MOLECULAR DIAGNOSIS BY LIGHTCYCLER SEPTIFAST IN THE PREEMPTIVE TREATMENT OF INVASIVE FUNGAL INFECTIONS: A 5 CASES REPORT |
Daniela Clerici
|
Archivo recibido
|
|
1036-P
|
RESPIRATORY SYNCYTIAL VIRUS INFECTION OUTBREAK IN CHILDREN WITH HEMATO-ONCOLOGICAL DISEASES |
Aysegul Unuvar
|
Archivo recibido
|
|
1038-P
|
IN VITRO ANTIBIOTIC SYNERGY ON MULTIDRUG-RESISTANT STRAINS OF PSEUDOMONAS AERUGINOSA ISOLATED FROM ONCOHAEMATOLOGICAL PATIENTS |
Giambattista Lobreglio
|
Archivo recibido
|
|
1039-P
|
IFN-GAMMA RELEASE ASSAY RESPONSES IN PATIENTS WITH CLINICAL SUSPICION FOR PULMONARY TUBERCULOSIS, AND IN HEALTH-CARE WORKERS WITH POTENTIAL FOR EXPOSURE TO M. TUBERCULOSIS |
Lobreglio Giambattista
|
Archivo recibido
|
 |
| Totales |
478 |
|
